UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED ~~JUNE~~June 30, ~~2019~~2020

Commission file number 1-9278

www.carlisle.com

CARLISLE COMPANIES INCORPORATED

(Exact name of registrant as specified in its charter)

Delaware

31-1168055

(State of incorporation)

(I.R.S. Employer Identification No.)

(480) 781-5000

(Telephone)

16430 North Scottsdale Road, Suite 400, Scottsdale,Arizona 85254

(Address of principal executive office, including zip code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock

CSL

New York Stock Exchange

Preferred stock purchase rights

n/a

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.


Yes			☒			No			☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).


Yes			☒			No			☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Yes			☐			No			☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).


Yes			☐			No			☒

On July ~~18, 2019,~~16, 2020, there were ~~56,606,220~~54,579,811 shares of the registrant's common stock outstanding, par value $1.00 per share.

Carlisle Companies Incorporated

Table of Contents


			Page
PART I

Item 1. Financial Statements			3

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited)			3

Condensed Consolidated Balance Sheets (Unaudited)			4

Condensed Consolidated Statement of Cash Flows (Unaudited)			5

Condensed Statement of Shareholders' Equity (Unaudited)			7

Notes to Condensed Consolidated Financial Statements (Unaudited)			8

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations			2324

Item 3. Quantitative and Qualitative Disclosure about Market Risk			3437

Item 4. Controls and Procedures			3437

PART II

Item 1. Legal Proceedings			3437

Item 1A. Risk Factors			3537

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			3538

Item 3. Defaults Upon Senior Securities			3538

Item 4. Mine Safety Disclosures			3538

Item 5. Other Information			3538

Item 6. Exhibits			3639

Signature			3740

PART I

Item 1. Financial Statements

Carlisle Companies Incorporated

Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited)


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended June 30,				Six Months Ended June 30,
(in millions, except per share amounts)	(in millions, except per share amounts)	2019		2018		2019		2018		(in millions, except per share amounts)	2020		2019		2020		2019
Revenues	Revenues	$	1,314.8	$	1,236.1	$	2,386.7	$	2,220.8	Revenues	$	1,024.2	$	1,314.8	$	2,054.4	$	2,386.7

Cost of goods sold	Cost of goods sold	920.6		903.9		1,703.9		1,639.2		Cost of goods sold	743.0		920.6		1,494.8		1,703.9
Selling and administrative expenses	Selling and administrative expenses	172.3		159.9		336.5		308.5		Selling and administrative expenses	153.1		172.3		315.0		336.5
Research and development expenses	Research and development expenses	15.4		14.2		29.8		28.1		Research and development expenses	14.1		15.4		28.5		29.8

Other operating (income) expense, net		(0.7)		(1.6)		(5.4)		(9.4)
Other operating expense (income), net										Other operating expense (income), net	0.6		(0.7)		—		(5.4)
Operating income	Operating income	207.2		159.7		321.9		254.4		Operating income	113.4		207.2		216.1		321.9
Interest expense, net	Interest expense, net	14.7		14.2		28.4		28.7		Interest expense, net	19.8		16.6		38.7		32.9
Other non-operating (income) expense, net		(0.6)		(0.7)		(1.0)		1.2
Loss on extinguishment of debt										Loss on extinguishment of debt	—		—		8.8		—
Interest income										Interest income	(2.7)		(1.9)		(3.4)		(4.5)
Other non-operating income, net										Other non-operating income, net	(0.7)		(0.6)		(1.2)		(1.0)
Income from continuing operations before income taxes	Income from continuing operations before income taxes	193.1		146.2		294.5		224.5		Income from continuing operations before income taxes	97.0		193.1		173.2		294.5
Provision for income taxes	Provision for income taxes	40.1		31.5		64.1		51.9		Provision for income taxes	21.6		40.1		36.0		64.1
Income from continuing operations	Income from continuing operations	153.0		114.7		230.4		172.6		Income from continuing operations	75.4		153.0		137.2		230.4

Discontinued operations:	Discontinued operations:									Discontinued operations:
(Loss) income before income taxes		—		(1.3)		—		297.7
Provision (benefit) for income taxes		0.1		(0.3)		(1.9)		47.0

Provision for (benefit from) income taxes										Provision for (benefit from) income taxes	—		0.1		—		(1.9)
(Loss) income from discontinued operations	(Loss) income from discontinued operations	(0.1)		(1.0)		1.9		250.7		(Loss) income from discontinued operations	—		(0.1)		—		1.9
Net income	Net income	$	152.9	$	113.7	$	232.3	$	423.3	Net income	$	75.4	$	152.9	$	137.2	$	232.3

Basic earnings per share attributable to common shares:	Basic earnings per share attributable to common shares:									Basic earnings per share attributable to common shares:
Income from continuing operations	Income from continuing operations	$	2.68	$	1.88	$	4.01	$	2.80	Income from continuing operations	$	1.37	$	2.68	$	2.47	$	4.01
(Loss) income from discontinued operations		—		(0.02)		0.03		4.07
Income from discontinued operations										Income from discontinued operations	—		—		—		0.03
Basic earnings per share	Basic earnings per share	$	2.68	$	1.86	$	4.04	$	6.87	Basic earnings per share	$	1.37	$	2.68	$	2.47	$	4.04

Diluted earnings per share attributable to common shares:	Diluted earnings per share attributable to common shares:									Diluted earnings per share attributable to common shares:
Income from continuing operations	Income from continuing operations	$	2.65	$	1.87	$	3.98	$	2.78	Income from continuing operations	$	1.36	$	2.65	$	2.45	$	3.98
(Loss) income from discontinued operations		—		(0.02)		0.03		4.04
Income from discontinued operations										Income from discontinued operations	—		—		—		0.03
Diluted earnings per share	Diluted earnings per share	$	2.65	$	1.85	$	4.01	$	6.82	Diluted earnings per share	$	1.36	$	2.65	$	2.45	$	4.01

Average shares outstanding (in thousands):
Average shares outstanding:										Average shares outstanding:
Basic	Basic	56,960		60,641		57,246		61,159		Basic	54.8		57.0		55.3		57.2
Diluted	Diluted	57,566		61,059		57,730		61,593		Diluted	55.2		57.6		55.8		57.7

Comprehensive income:	Comprehensive income:									Comprehensive income:
Net income	Net income	$	152.9	$	113.7	$	232.3	$	423.3	Net income	$	75.4	$	152.9	$	137.2	$	232.3
Other comprehensive income:
Foreign currency (losses) gains		(3.6)		(35.4)		0.3		(13.2)
Other comprehensive income (loss):										Other comprehensive income (loss):
Foreign currency gains (losses)										Foreign currency gains (losses)	7.8		(3.6)		(20.5)		0.3
Amortization of unrecognized net periodic benefit costs, net of tax	Amortization of unrecognized net periodic benefit costs, net of tax	0.6		1.1		1.3		2.0		Amortization of unrecognized net periodic benefit costs, net of tax	1.0		0.6		2.0		1.3
Other, net of tax	Other, net of tax	(1.6)		0.3		—		0.5		Other, net of tax	0.7		(1.6)		(17.5)		—
Other comprehensive (loss) income		(4.6)		(34.0)		1.6		(10.7)
Other comprehensive income (loss)										Other comprehensive income (loss)	9.5		(4.6)		(36.0)		1.6
Comprehensive income	Comprehensive income	$	148.3	$	79.7	$	233.9	$	412.6	Comprehensive income	$	84.9	$	148.3	$	101.2	$	233.9

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Carlisle Companies Incorporated

Condensed Consolidated Balance Sheets (Unaudited)


(in millions, except share and per share amounts)		June 30, 2019		December 31, 2018
(in millions, except per share amounts)						(in millions, except per share amounts)	June 30, 2020		December 31, 2019
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	422.0	$	803.6	Cash and cash equivalents	$	737.7	$	351.2
Receivables, net of allowance of $5.7 million and $5.1 million, respectively		915.6		698.3
Receivables, net of allowance for credit losses of $7.6 million and $6.6 million, respectively						Receivables, net of allowance for credit losses of $7.6 million and $6.6 million, respectively	692.5		682.5
Inventories, net	Inventories, net	505.6		457.5		Inventories, net	547.8		510.6
Contract assets						Contract assets	101.9		100.5
Prepaid expenses	Prepaid expenses	19.0		22.0		Prepaid expenses	25.2		30.5
Other current assets	Other current assets	60.0		75.3		Other current assets	47.8		76.7
Total current assets	Total current assets	1,922.2		2,056.7		Total current assets	2,152.9		1,752.0

Property, plant, and equipment, net	Property, plant, and equipment, net	778.6		760.1		Property, plant, and equipment, net	764.3		783.5
Goodwill, net	Goodwill, net	1,530.9		1,441.8		Goodwill, net	1,708.3		1,716.3
Other intangible assets, net	Other intangible assets, net	1,058.6		967.7		Other intangible assets, net	1,083.9		1,140.6
Other long-term assets	Other long-term assets	106.4		22.9		Other long-term assets	98.9		103.6
Total assets	Total assets	$	5,396.7	$	5,249.2	Total assets	$	5,808.3	$	5,496.0

LIABILITIES AND EQUITY	LIABILITIES AND EQUITY					LIABILITIES AND EQUITY
Current liabilities:	Current liabilities:					Current liabilities:

Accounts payable	Accounts payable	$	374.4	$	312.1	Accounts payable	$	321.3	$	327.3
Accrued liabilities and other		248.8		258.0
Deferred revenue		26.7		25.5
Accrued and other current liabilities						Accrued and other current liabilities	259.9		294.5
Contract liabilities						Contract liabilities	31.9		27.0
Current portion of debt						Current portion of debt	0.8		250.2

Total current liabilities	Total current liabilities	649.9		595.6		Total current liabilities	613.9		899.0

Long-term liabilities:	Long-term liabilities:					Long-term liabilities:
Long-term debt		1,589.4		1,587.8
Deferred revenue		208.9		201.9
Long-term debt, less current portion						Long-term debt, less current portion	2,077.2		1,341.4
Contract liabilities						Contract liabilities	226.9		220.4
Other long-term liabilities	Other long-term liabilities	365.3		266.5		Other long-term liabilities	374.1		392.4
Total long-term liabilities	Total long-term liabilities	2,163.6		2,056.2		Total long-term liabilities	2,678.2		1,954.2

Shareholders' equity:	Shareholders' equity:					Shareholders' equity:
Preferred stock, $1 par value per share (5,000,000 shares authorized and unissued)		—		—
Common stock, $1 par value per share (200,000,000 shares; 56,420,192 and 57,957,912 shares outstanding, respectively)		78.7		78.7
Preferred stock, $1 par value per share (5.0 shares authorized and unissued)						Preferred stock, $1 par value per share (5.0 shares authorized and unissued)	—		—
Common stock, $1 par value per share (200.0 shares authorized; 54.4 and 55.7 shares outstanding, respectively)						Common stock, $1 par value per share (200.0 shares authorized; 54.4 and 55.7 shares outstanding, respectively)	78.7		78.7
Additional paid-in capital	Additional paid-in capital	397.3		383.8		Additional paid-in capital	424.5		413.7
Deferred compensation equity	Deferred compensation equity	3.0		8.0		Deferred compensation equity	3.3		2.9
Treasury shares, at cost (22,056,282 and 20,534,652 shares, respectively)		(1,312.8)		(1,102.4)
Treasury shares, at cost (24.0 and 22.7 shares, respectively)						Treasury shares, at cost (24.0 and 22.7 shares, respectively)	(1,632.7)		(1,449.7)
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(120.5)		(122.1)		Accumulated other comprehensive loss	(160.1)		(124.1)
Retained earnings	Retained earnings	3,537.5		3,351.4		Retained earnings	3,802.5		3,721.3
Total shareholders' equity	Total shareholders' equity	2,583.2		2,597.4		Total shareholders' equity	2,516.2		2,642.8
Total liabilities and equity	Total liabilities and equity	$	5,396.7	$	5,249.2	Total liabilities and equity	$	5,808.3	$	5,496.0

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Carlisle Companies Incorporated

Condensed Consolidated Statements of Cash Flows (Unaudited)


		Six Months Ended June 30,							Six Months Ended June 30,
(in millions)	(in millions)	2019		2018		(in millions)	2020		2019
Operating activities:	Operating activities:					Operating activities:
Net income	Net income	$	232.3	$	423.3	Net income	$	137.2	$	232.3
Reconciliation of net income to net cash provided by operating activities:	Reconciliation of net income to net cash provided by operating activities:					Reconciliation of net income to net cash provided by operating activities:
Depreciation	Depreciation	43.8		43.8		Depreciation	49.1		43.8
Amortization	Amortization	56.2		53.5		Amortization	63.7		56.2
Lease expense	Lease expense	13.2		—		Lease expense	14.1		13.2

Stock-based compensation, net of tax benefit		11.3		13.4
Stock-based compensation						Stock-based compensation	14.9		11.3
Loss on extinguishment of debt						Loss on extinguishment of debt	8.8		—
Deferred taxes	Deferred taxes	(1.9)		(8.9)		Deferred taxes	(1.1)		(1.9)
Gain on sale of discontinued operation, net of tax		—		(247.6)

Other operating activities, net	Other operating activities, net	7.9		(9.4)		Other operating activities, net	11.5		7.9
Changes in assets and liabilities, excluding effects of acquisitions:	Changes in assets and liabilities, excluding effects of acquisitions:					Changes in assets and liabilities, excluding effects of acquisitions:
Receivables	Receivables	(198.0)		(194.9)		Receivables	(11.8)		(184.6)
Inventories	Inventories	(6.4)		(60.2)		Inventories	(48.4)		(6.4)
Contract assets						Contract assets	(1.4)		(13.4)
Prepaid expenses and other assets	Prepaid expenses and other assets	26.9		3.2		Prepaid expenses and other assets	29.4		26.9
Accounts payable	Accounts payable	71.0		66.3		Accounts payable	(5.0)		71.0
Accrued liabilities and other		(47.3)		(91.1)
Deferred revenues		7.2		8.7
Accrued and other current liabilities						Accrued and other current liabilities	(31.8)		(47.3)
Contract liabilities						Contract liabilities	11.5		7.2
Other long-term liabilities	Other long-term liabilities	(19.1)		(2.9)		Other long-term liabilities	(14.4)		(19.1)
Net cash provided by (used in) operating activities		197.1		(2.8)
Net cash provided by operating activities						Net cash provided by operating activities	226.3		197.1

Investing activities:	Investing activities:					Investing activities:
Capital expenditures						Capital expenditures	(48.5)		(41.0)
Acquisitions, net of cash acquired	Acquisitions, net of cash acquired	(272.0)		(19.3)		Acquisitions, net of cash acquired	(2.4)		(272.0)
Capital expenditures		(41.0)		(66.9)
Proceeds from sale of discontinued operation		—		754.6

Other investing activities, net	Other investing activities, net	1.1		5.7		Other investing activities, net	0.9		1.1
Net cash (used in) provided by investing activities		(311.9)		674.1
Net cash used in investing activities						Net cash used in investing activities	(50.0)		(311.9)

Financing activities:	Financing activities:					Financing activities:

Proceeds from notes						Proceeds from notes	740.7		—
Repayment of notes						Repayment of notes	(258.5)		—
Borrowings from revolving credit facility						Borrowings from revolving credit facility	500.0		—
Repayments of revolving credit facility						Repayments of revolving credit facility	(500.0)		—
Financing costs						Financing costs	(24.2)		—
Repurchases of common stock	Repurchases of common stock	(232.1)		(235.7)		Repurchases of common stock	(191.8)		(232.1)
Dividends paid	Dividends paid	(46.2)		(45.6)		Dividends paid	(56.0)		(46.2)
Proceeds from exercise of stock options	Proceeds from exercise of stock options	20.5		5.0		Proceeds from exercise of stock options	11.4		20.5
Withholding tax paid related to stock-based compensation	Withholding tax paid related to stock-based compensation	(9.3)		(9.6)		Withholding tax paid related to stock-based compensation	(6.4)		(9.3)
Other financing activities, net	Other financing activities, net	(0.1)		—		Other financing activities, net	(0.5)		(0.1)
Net cash used in financing activities		(267.2)		(285.9)
Net cash provided by (used in) financing activities						Net cash provided by (used in) financing activities	214.7		(267.2)

Effect of foreign currency exchange rate changes on cash and cash equivalents	Effect of foreign currency exchange rate changes on cash and cash equivalents	0.4		—		Effect of foreign currency exchange rate changes on cash and cash equivalents	(4.5)		0.4
Change in cash and cash equivalents	Change in cash and cash equivalents	(381.6)		385.4		Change in cash and cash equivalents	386.5		(381.6)
Less: change in cash and cash equivalents of discontinued operations		—		1.3

Cash and cash equivalents at beginning of period	Cash and cash equivalents at beginning of period	803.6		378.3		Cash and cash equivalents at beginning of period	351.2		803.6
Cash and cash equivalents at end of period	Cash and cash equivalents at end of period	$	422.0	$	762.4	Cash and cash equivalents at end of period	$	737.7	$	422.0

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Carlisle Companies Incorporated

Condensed Consolidated Statement of Shareholders’ Equity (Unaudited)


		Common Stock					Additional Paid-In Capital		Deferred Compensation Equity		Accumulated Other Comprehensive Income (Loss)		Retained Earnings	Shares in Treasury							Total Shareholders' Equity				Common Stock								Additional Paid-In Capital			Deferred Compensation Equity		Accumulated Other Comprehensive Income (Loss)			Retained Earnings			Shares in Treasury			Total Shareholders' Equity
(in millions, except per share amounts)	(in millions, except per share amounts)	Shares	Amount													Shares			Cost					(in millions, except per share amounts)			Shares			Amount					Additional Paid-In Capital		Deferred Compensation Equity			Accumulated Other Comprehensive Income (Loss)			Retained Earnings		Shares	Cost		Total Shareholders' Equity
Balance as of March 31, 2018		60.7	$	78.7	$	357.6	$	11.1	$	(68.9)	$	3,120.3	17.7	$	(778.0)	$	2,720.8

Net income		—	—		—		—		—		113.7		—	—		113.7
Other comprehensive loss, net of tax		—	—		—		—		(34.0)		—		—	—		(34.0)
Cash dividends - $0.37 per share		—	—		—		—		—		(22.5)		—	—		(22.5)
Repurchases of common stock		(1.0)	—		—		—		—		—		1.0	(111.3)		(111.3)
Issuances and deferrals, net for stock based compensation¹		0.1	—		8.2		(3.3)		—		—		(0.1)	0.7		5.6
Balance as of June 30, 2018		59.8	$	78.7	$	365.8	$	7.8	$	(102.9)	$	3,211.5	18.6	$	(888.6)	$	2,672.3

Balance as of March 31, 2019	Balance as of March 31, 2019	56.8	$	78.7	$	390.1	$	7.8	$	(115.9)	$	3,407.5	21.6	$	(1,243.5)	$	2,524.7	Balance as of March 31, 2019		56.8		$	78.7		$	390.1		$	7.8		$	(115.9)	$	3,407.5		21.6		$	(1,243.5)		$	2,524.7

Net income	Net income	—	—		—		—		—		152.9		—	—		152.9		Net income		—		—			—			—			—		152.9			—		—			152.9
Other comprehensive loss, net of tax	Other comprehensive loss, net of tax	—	—		—		—		(4.6)		—		—	—		(4.6)		Other comprehensive loss, net of tax		—		—			—			—			(4.6)		—			—		—			(4.6)
Cash dividends - $0.40 per share	Cash dividends - $0.40 per share	—	—		—		—		—		(22.9)		—	—		(22.9)		Cash dividends - $0.40 per share		—		—			—			—			—		(22.9)			—		—			(22.9)
Repurchases of common stock	Repurchases of common stock	(0.6)	—		—		—		—		—		0.6	(75.0)		(75.0)		Repurchases of common stock		(0.6)		—			—			—			—		—			0.6		(75.0)			(75.0)
Issuances and deferrals, net for stock based compensation¹		0.2	—		7.2		(4.8)		—		—		(0.2)	5.7		8.1
Issuances and deferrals, net for stock based compensation⁽¹⁾																		Issuances and deferrals, net for stock based compensation⁽¹⁾		0.2		—			7.2			(4.8)			—		—			(0.2)		5.7			8.1
Balance as of June 30, 2019	Balance as of June 30, 2019	56.4	$	78.7	$	397.3	$	3.0	$	(120.5)	$	3,537.5	22.0	$	(1,312.8)	$	2,583.2	Balance as of June 30, 2019		56.4		$	78.7		$	397.3		$	3.0		$	(120.5)	$	3,537.5		22.0		$	(1,312.8)		$	2,583.2

Balance as of March 31, 2020																		Balance as of March 31, 2020		54.9		$	78.7		$	418.7		$	3.4		$	(169.6)	$	3,754.8		23.5		$	(1,567.5)		$	2,518.5

Net income																		Net income		—		—			—			—			—		75.4			—		—			75.4
Other comprehensive income, net of tax																		Other comprehensive income, net of tax		—		—			—			—			9.5		—			—		—			9.5
Cash dividends - $0.50 per share																		Cash dividends - $0.50 per share		—		—			—			—			—		(27.7)			—		—			(27.7)
Repurchases of common stock																		Repurchases of common stock		(0.5)		—			—			—			—		—			0.5		(66.5)			(66.5)
Issuances and deferrals, net for stock based compensation⁽¹⁾																		Issuances and deferrals, net for stock based compensation⁽¹⁾		—		—			5.8			(0.1)			—		—			—		1.3			7.0
Balance as of June 30, 2020																		Balance as of June 30, 2020		54.4		$	78.7		$	424.5		$	3.3		$	(160.1)	$	3,802.5		24.0		$	(1,632.7)		$	2,516.2

^1.(1)Issuances and deferrals, net for ~~stock based~~stock-based compensation reflects share activity related to option exercises, restricted and performance shares vested, and net issuances and deferrals associated with deferred compensation equity.

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Carlisle Companies Incorporated

Condensed Consolidated Statement of Shareholders’ Equity (Unaudited)


		Common Stock					Additional Paid-In Capital		Deferred Compensation Equity		Accumulated Other Comprehensive Income (Loss)		Retained Earnings	Shares in Treasury							Total Shareholders' Equity				Common Stock								Additional Paid-In Capital			Deferred Compensation Equity		Accumulated Other Comprehensive Income (Loss)			Retained Earnings			Shares in Treasury			Total Shareholders' Equity
(in millions, except per share amounts)	(in millions, except per share amounts)	Shares	Amount													Shares			Cost					(in millions, except per share amounts)			Shares			Amount					Additional Paid-In Capital		Deferred Compensation Equity			Accumulated Other Comprehensive Income (Loss)			Retained Earnings		Shares	Cost		Total Shareholders' Equity
Balance as of December 31, 2017		61.8	$	78.7	$	353.7	$	10.4	$	(85.7)	$	2,820.8	16.6	$	(649.6)	$	2,528.3
Adoption of accounting standards		—	—		—		—		(6.5)		13.0		—	—		6.5
Net income		—	—		—		—		—		423.3		—	—		423.3
Other comprehensive loss, net of tax		—	—		—		—		(10.7)		—		—	—		(10.7)
Cash dividends - $0.74 per share		—	—		—		—		—		(45.6)		—	—		(45.6)
Repurchases of common stock		(2.2)	—		—		—		—		—		2.2	(240.6)		(240.6)
Issuances and deferrals, net for stock based compensation¹		0.2	—		12.1		(2.6)		—		—		(0.2)	1.6		11.1
Balance as of June 30, 2018		59.8	$	78.7	$	365.8	$	7.8	$	(102.9)	$	3,211.5	18.6	$	(888.6)	$	2,672.3

Balance as of December 31, 2018	Balance as of December 31, 2018	57.9	$	78.7	$	383.8	$	8.0	$	(122.1)	$	3,351.4	20.5	$	(1,102.4)	$	2,597.4	Balance as of December 31, 2018		57.9		$	78.7		$	383.8		$	8.0		$	(122.1)	$	3,351.4		20.5		$	(1,102.4)		$	2,597.4

Net income	Net income	—	—		—		—		—		232.3		—	—		232.3		Net income		—		—			—			—			—		232.3			—		—			232.3
Other comprehensive income, net of tax	Other comprehensive income, net of tax	—	—		—		—		1.6		—		—	—		1.6		Other comprehensive income, net of tax		—		—			—			—			1.6		—			—		—			1.6
Cash dividends - $0.80 per share	Cash dividends - $0.80 per share	—	—		—		—		—		(46.2)		—	—		(46.2)		Cash dividends - $0.80 per share		—		—			—			—			—		(46.2)			—		—			(46.2)
Repurchases of common stock	Repurchases of common stock	(1.9)	—		—		—		—		—		1.9	(224.9)		(224.9)		Repurchases of common stock		(1.9)		—			—			—			—		—			1.9		(224.9)			(224.9)
Issuances and deferrals, net for stock based compensation¹		0.4	—		13.5		(5.0)		—		—		(0.4)	14.5		23.0
Issuances and deferrals, net for stock based compensation⁽¹⁾																		Issuances and deferrals, net for stock based compensation⁽¹⁾		0.4		—			13.5			(5.0)			—		—			(0.4)		14.5			23.0
Balance as of June 30, 2019	Balance as of June 30, 2019	56.4	$	78.7	$	397.3	$	3.0	$	(120.5)	$	3,537.5	22.0	$	(1,312.8)	$	2,583.2	Balance as of June 30, 2019		56.4		$	78.7		$	397.3		$	3.0		$	(120.5)	$	3,537.5		22.0		$	(1,312.8)		$	2,583.2

Balance as of December 31, 2019																		Balance as of December 31, 2019		55.7		$	78.7		$	413.7		$	2.9		$	(124.1)	$	3,721.3		22.7		$	(1,449.7)		$	2,642.8

Net income																		Net income		—		—			—			—			—		137.2			—		—			137.2
Other comprehensive loss, net of tax																		Other comprehensive loss, net of tax		—		—			—			—			(36.0)		—			—		—			(36.0)
Cash dividends - $1.00 per share																		Cash dividends - $1.00 per share		—		—			—			—			—		(56.0)			—		—			(56.0)
Repurchases of common stock																		Repurchases of common stock		(1.5)		—			—			—			—		—			1.5		(191.8)			(191.8)
Issuances and deferrals, net for stock based compensation⁽¹⁾																		Issuances and deferrals, net for stock based compensation⁽¹⁾		0.2		—			10.8			0.4			—		—			(0.2)		8.8			20.0
Balance as of June 30, 2020																		Balance as of June 30, 2020		54.4		$	78.7		$	424.5		$	3.3		$	(160.1)	$	3,802.5		24.0		$	(1,632.7)		$	2,516.2

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

Carlisle Companies Incorporated

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1—Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared by Carlisle Companies Incorporated (the "Company" or "Carlisle"). The accompanying unaudited Condensed Consolidated Financial Statements do not include all disclosures as required by accounting principles generally accepted in the United States of America ("United States" or "U.S."), and should be read in conjunction with the Company’s audited Consolidated Financial Statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, ~~2018.~~2019.

The accompanying unaudited Condensed Consolidated Financial Statements are prepared in conformity with accounting principles generally accepted in the U.S. and, of necessity, include some amounts that are based upon management estimates and judgments. The accompanying unaudited Condensed Consolidated Financial Statements include assets, liabilities, revenues and expenses of all majority-owned subsidiaries. Intercompany transactions and balances are eliminated in consolidation.

In the Company's opinion, the accompanying unaudited Condensed Consolidated Financial Statements contain all adjustments, consisting solely of adjustments of a normal, recurring nature, ~~except as disclosed in Note 2 for new accounting standards adopted,~~ necessary to present fairly the financial position, results of operations and cash flows for the periods presented. During the first quarter of 2020, the Company revised the Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Cash Flows to reclassify contract assets from receivables, net to a separately disclosed line item. During the third quarter of 2019, the Company revised the Condensed Consolidated Statements of Income to reclassify interest income from interest expense, net to a separately disclosed line item. The Company has reclassified certain prior period amounts to conform to the current period presentation.

Note 2—New Accounting Pronouncements

New Accounting Standards Adopted

In ~~February~~June 2016, the ~~FASB~~Financial Accounting Standards Board ("FASB") issued ~~ASU 2016-02, Leases~~Accounting Standards Update 2016-13, Measurement of Credit Losses on Financial Instruments (Topic ~~842)~~326) ("ASU ~~2016-02"~~2016-13") which ~~requires lessees~~adds to ~~recognize a lease liability for~~accounting principles generally accepted in the obligation to make lease payments, measured at the present value on a discounted basis, and a right-of-use ("ROU") asset for the right to use the underlying asset for the duration of the lease term, measuredU.S. an impairment model (known as the ~~lease liability amount adjusted for lease prepayments, lease incentives received, and initial direct costs.~~ current expected credit losses model) that is based on expected losses rather than incurred losses. Under ASU 2016-13, an entity recognizes, as an allowance, its estimate of lifetime expected credit losses, which the FASB believes will result in more timely recognition of such losses.

The Company adopted ASU ~~2016-02~~2016-13 and all related amendments ~~("ASC 842") on~~effective January 1, ~~2019,~~2020, using the ~~alternative~~ modified retrospective method, ~~also known~~which allows for a cumulative-effect adjustment to the statement of financial position as of the ~~transition relief method, permitted under ASC 842,~~beginning of the first reporting period in which the guidance is effective. Periods prior to the adoption date that are presented for comparative purposes are not adjusted. The adoption of this standard did not require restatement of prior periods. In addition, the Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification. The standardan implementation adjustment and did not materially impact the Company's consolidated net income or cash flows.

~~Following is a summary~~Changes in the Company's allowance for credit losses by segment follows:


(in millions)	CCM		CIT		CFT		CBF		Corporate		Total
Balance as of January 1, 2020	$	2.2	$	1.6	$	1.1	$	1.2	$	0.5	$	6.6
Current period provision	1.2		—		0.1		0.3		—		1.6

Amounts written off	(0.4)		(0.2)		—		—		—		(0.6)
Balance as of June 30, 2020	$	3.0	$	1.4	$	1.2	$	1.5	$	0.5	$	7.6

Receivables are stated at amortized cost net of allowance for credit losses. The Company performs ongoing evaluations of its customers’ current creditworthiness, as determined by the ~~effects~~review of ~~adopting ASC 842~~their credit information to determine if events have occurred subsequent to the recognition of revenue and the related receivable that provides evidence that such receivable will be realized in an amount less than that recognized at the time of sale. Estimates of credit losses are based on ~~the Condensed Consolidated Balance Sheet:~~historical losses, current economic conditions, geographic considerations, and in some cases, evaluating specific customer accounts for risk of loss.

June 30, 2019
(in millions) As Reported
Balances Without Adoption of
ASC 842
Effect of Change Higher/(Lower)
Other current assets $ 60.0 $ 60.5 $ (0.5)
Other long-term assets 106.4 36.8 69.6
Accrued liabilities and other 248.8 227.4 21.4
Other long-term liabilities 365.3 317.6 47.7

Note 3—Segment Information

The Company has organized its operations into ~~four~~4 segments, based on the products it sells, as follows:

Carlisle Construction Materials ("CCM")—the principal products of this segment are rubber (EPDM), thermoplastic polyolefin (TPO) and polyvinyl chloride (PVC) roofing membranes used predominantly on non-residential low-sloped roofs, related roofing accessories, including flashings, fasteners, sealing tapes and coatings and waterproofing products. In addition, CCM offers a broad range of specialty polyurethane products and solutions across a broad ~~diversity~~array of markets and applications, and metal panel roofing primarily for residential and commercial markets. CCM also manufactures and distributes energy-efficient rigid foam insulation panels for

substantially all roofing applications. The markets served primarily include new construction, re-roofing and maintenance of low-sloped roofs, water containment, HVAC sealants and coatings and waterproofing.

Carlisle Interconnect Technologies ("CIT")—the principal products of this segment are high-performance wire, cable, connectors, contacts and cable assemblies for the transfer of power and data primarily for the aerospace, ~~medical,~~ defense electronics, test and measurement equipment and select industrial ~~markets.~~markets, and highly engineered products and services to the medical device market.

Carlisle Fluid Technologies ("CFT")—the principal products of this segment are industrial liquid and powder finishing equipment and integrated system solutions for spraying, pumping, mixing, metering and curing of a variety of coatings used in the transportation, general industrial, ~~transportation, auto refinishing,~~ protective coating, wood, specialty and ~~specialty markets, and sealants and adhesives.~~ auto refinishing markets.

Carlisle Brake & Friction ("CBF")—the principal products of this segment include high-performance brakes and friction material and clutch and transmission friction material for the construction, agriculture, mining, on-highway, aerospace and motor sports markets.

A summary of segment information follows:


		Three Months Ended June 30,															Three Months Ended June 30,
		2019						2018							2020				2019
(in millions)	(in millions)	Revenues		Operating Income (Loss)		Revenues		Operating Income (Loss)		(in millions)	Revenues		Operating Income (Loss)		Revenues		Operating Income (Loss)
Carlisle Construction Materials	Carlisle Construction Materials	$	915.0	$	182.5	$	828.6	$	141.4	Carlisle Construction Materials	$	734.9	$	137.6	$	915.0	$	182.5
Carlisle Interconnect Technologies	Carlisle Interconnect Technologies	245.4		35.9		237.7		27.5		Carlisle Interconnect Technologies	184.0		(1.5)		245.4		35.9
Carlisle Fluid Technologies	Carlisle Fluid Technologies	67.3		3.3		73.3		7.8		Carlisle Fluid Technologies	46.5		(5.2)		67.3		3.3
Carlisle Brake & Friction	Carlisle Brake & Friction	87.1		8.3		96.5		2.9		Carlisle Brake & Friction	58.8		(1.6)		87.1		8.3
Segment Total		1,314.8		230.0		1,236.1		179.6
Corporate and unallocated¹		—		(22.8)		—		(19.9)
Segment total										Segment total	1,024.2		129.3		1,314.8		230.0
Corporate and unallocated⁽¹⁾										Corporate and unallocated⁽¹⁾	—		(15.9)		—		(22.8)
Total	Total	$	1,314.8	$	207.2	$	1,236.1	$	159.7	Total	$	1,024.2	$	113.4	$	1,314.8	$	207.2

		Six Months Ended June 30,															Six Months Ended June 30,
		2019						2018							2020				2019
(in millions)	(in millions)	Revenues		Operating Income (Loss)		Revenues		Operating Income (Loss)		(in millions)	Revenues		Operating Income (Loss)		Revenues		Operating Income (Loss)
Carlisle Construction Materials	Carlisle Construction Materials	$	1,586.1	$	275.4	$	1,427.2	$	217.2	Carlisle Construction Materials	$	1,411.3	$	245.3	$	1,586.1	$	275.4
Carlisle Interconnect Technologies	Carlisle Interconnect Technologies	491.8		66.5		462.0		54.7		Carlisle Interconnect Technologies	408.5		14.9		491.8		66.5
Carlisle Fluid Technologies	Carlisle Fluid Technologies	130.4		9.7		136.8		13.5		Carlisle Fluid Technologies	104.8		(2.4)		130.4		9.7
Carlisle Brake & Friction	Carlisle Brake & Friction	178.4		14.8		194.8		7.4		Carlisle Brake & Friction	129.8		(5.4)		178.4		14.8
Segment total	Segment total	2,386.7		366.4		2,220.8		292.8		Segment total	2,054.4		252.4		2,386.7		366.4
Corporate and unallocated¹		—		(44.5)		—		(38.4)
Corporate and unallocated⁽¹⁾										Corporate and unallocated⁽¹⁾	—		(36.3)		—		(44.5)
Total	Total	$	2,386.7	$	321.9	$	2,220.8	$	254.4	Total	$	2,054.4	$	216.1	$	2,386.7	$	321.9

^1.(1)Corporate operating loss includes other unallocated costs, primarily general corporate expenses.

Note 4—Acquisitions

~~Petersen Aluminum Corporation~~ Providien, LLC

On ~~January 11,~~November 20, 2019, the Company ~~acquired 100%~~completed its acquisition of ~~the equity of Petersen Aluminum Corporation~~Providien, LLC ("~~Petersen"~~Providien"), for consideration of ~~$207.2~~$331.3 million, including ~~$5.2~~$3.4 million of cash acquired and post-closing adjustments, which were finalized in the first quarter of 2019. Petersen is a manufacturer and distributor of market leading architectural metal roof panels, steel and aluminum flat sheets and coils, wall panels, perimeter roof edge systems and related accessories for commercial, residential, institutional, industrial and agricultural markets.

In the three months ended June 30, 2019, and the period from January 11, 2019 to June 30, 2019, Petersen contributed revenues of $48.3 million and $83.8 million, respectively, and operating income of $3.7 million and $3.6 million, respectively, to the Company's consolidated results. The results of operations of the acquired business are reported as part of the CCM segment.

quarter of 2020. The product lines acquired include thermoforming, medical device contract manufacturing, precision machining and metals, and medical injection molding for the global medical device market.

The following table summarizes the consideration transferred to acquire ~~Petersen~~the Providien product lines and related operating and non-operating assets and liabilities and the preliminary allocation of the purchase price among ~~the assets acquired and liabilities assumed.~~them. The acquisition has been accounted for using the acquisition method of accounting in accordance with ~~ASC~~Accounting Standards Codification ("ASC") 805, Business Combinations, which requires that consideration be allocated to the acquired assets and assumed liabilities based upon their acquisition date fair values with the remainder allocated to goodwill. The fair values are preliminary and subject to change pending receipt of the final valuation studies.


		Preliminary Allocation		Measurement Period Adjustments		Preliminary Allocation				Preliminary Allocation			Measurement Period Adjustments			Preliminary Allocation
(in millions)	(in millions)	As of 1/11/2019						6/30/2019	(in millions)			As of 11/20/2019			Measurement Period Adjustments			As of 6/30/2020
Total cash consideration transferred	Total cash consideration transferred	$	207.2	$	—	$	207.2	Total cash consideration transferred		$	332.1		$	(0.8)		$	331.3
Recognized amounts of identifiable assets acquired and liabilities assumed:	Recognized amounts of identifiable assets acquired and liabilities assumed:							Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash and cash equivalents	Cash and cash equivalents	5.2		—		5.2		Cash and cash equivalents		3.4			—			3.4
Receivables, net	Receivables, net	11.5		—		11.5		Receivables, net		9.8			—			9.8
Inventories, net	Inventories, net	39.5		(0.3)		39.2		Inventories, net		2.7			—			2.7
Contract assets								Contract assets		29.1			—			29.1
Prepaid expenses and other current assets	Prepaid expenses and other current assets	2.1		—		2.1		Prepaid expenses and other current assets		2.3			—			2.3
Property, plant and equipment	Property, plant and equipment	17.8		—		17.8		Property, plant and equipment		12.9			—			12.9
Definite-lived intangible assets	Definite-lived intangible assets	109.3		0.8		110.1		Definite-lived intangible assets		135.4			(2.7)			132.7
Other long-term assets	Other long-term assets	9.5		—		9.5		Other long-term assets		7.1			(0.3)			6.8
Accounts payable	Accounts payable	(5.9)		—		(5.9)		Accounts payable		(6.0)			—			(6.0)
Income tax payable	Income tax payable	1.7		—		1.7		Income tax payable		(0.7)			—			(0.7)
Accrued liabilities and other		(8.7)		—		(8.7)
Accrued and other current liabilities								Accrued and other current liabilities		(7.0)			—			(7.0)
Other long-term liabilities	Other long-term liabilities	(12.4)		—		(12.4)		Other long-term liabilities		(8.1)			0.5			(7.6)
Deferred income taxes	Deferred income taxes	(25.4)		(0.2)		(25.6)		Deferred income taxes		(27.1)			6.9			(20.2)
Total identifiable net assets	Total identifiable net assets	144.2		0.3		144.5		Total identifiable net assets		153.8			4.4			158.2
Goodwill	Goodwill	$	63.0	$	(0.3)	$	62.7	Goodwill		$	178.3		$	(5.2)		$	173.1

The preliminary goodwill recognized in the acquisition of Providien reflects market participant synergies attributable to significant raw material purchase synergies with CIT, other administrative synergies, the value of the assembled workforce to Carlisle and opportunities for product line expansions. The Company acquired $9.8 million of gross contractual accounts receivable, of which less than $0.1 million was not expected to be collected at the date of acquisition. All of the goodwill has been preliminarily assigned to the CIT reporting unit, which aligns with the CIT reportable segment. Goodwill totaled $173.1 million, of which $66.5 million is preliminarily deductible for tax purposes. The $132.7 million preliminary value allocated to definite-lived intangible assets consists of $108.7 million of customer relationships with a useful life between 13 to 37 years, various acquired technologies of $19.5 million with a useful life of six to 11 years and trade names of $4.4 million with a useful life of two to five years. The Company has also recorded, as part of the purchase price allocation, deferred tax liabilities related to intangible assets of approximately $20.2 million.

Petersen Aluminum Corporation

On January 11, 2019, the Company acquired 100% of the equity of Petersen Aluminum Corporation ("Petersen"), for consideration of $207.2 million, including $5.2 million of cash acquired and post-closing adjustments, which were finalized in the first quarter of 2019. The products acquired include architectural metal roof panels, steel and aluminum flat sheets and coils, wall panels, perimeter roof edge systems and related accessories for commercial, residential, institutional, industrial and agricultural markets.

In the three months ended June 30, 2019, and the period from January 11, 2019 to June 30, 2019, the related product lines contributed revenues of $48.3 million and $83.8 million, respectively, and operating income of $3.7 million and $3.6 million, respectively, to the Company's consolidated results. The results of operations of the acquired business are reported as part of the CCM segment.

The ~~preliminary~~following table summarizes the consideration transferred to acquire Petersen and the allocation of the purchase price among the assets acquired and liabilities assumed. The acquisition has been accounted for using the

acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires that consideration be allocated to the acquired assets and assumed liabilities based upon their acquisition date fair values with the remainder allocated to goodwill.


	Preliminary Allocation		Measurement Period Adjustments		Final Allocation
(in millions)	As of 1/11/2019						As of 12/31/2019
Total cash consideration transferred	$	207.2	$	—	$	207.2
Recognized amounts of identifiable assets acquired and liabilities assumed:
Cash and cash equivalents	5.2		—		5.2
Receivables, net	11.5		—		11.5
Inventories, net	39.5		(0.3)		39.2
Prepaid expenses and other current assets	2.1		—		2.1
Property, plant and equipment	17.8		—		17.8
Definite-lived intangible assets	109.3		0.8		110.1
Other long-term assets	9.5		—		9.5
Accounts payable	(5.9)		—		(5.9)
Income tax payable	1.7		—		1.7
Accrued and other current liabilities	(8.7)		—		(8.7)
Other long-term liabilities	(12.4)		(0.1)		(12.5)
Deferred income taxes	(25.4)		(0.2)		(25.6)
Total identifiable net assets	144.2		0.2		144.4
Goodwill	$	63.0	$	(0.2)	$	62.8

The goodwill recognized in the acquisition of Petersen reflects market participant synergies attributable to significant raw material purchase synergies with CCM, other administrative synergies and the assembled workforce to Carlisle, in addition to opportunities for product line expansions. The Company acquired $11.6 million of gross contractual accounts receivable, of which $0.1 million was not expected to be collected at the date of acquisition. All of the goodwill has been ~~preliminarily~~ assigned to the CCM reporting unit, which aligns with the CCM reportable segment, and ~~none~~NaN of the goodwill is deductible for tax purposes. The $110.1 million ~~preliminary~~ value allocated to definite-lived intangible assets consists of $79.7 million of customer relationships with a useful life of 11 years, $27.9 million of trade names with a useful life of 17 years and various acquired technologies of $2.5 million with a useful life of 10 years. In accordance with the purchase agreement, Carlisle is indemnified for up to $5.2 million, and recorded an indemnification asset of $5.2 million in other long-term assets relating to the indemnification for pre-acquisition income tax liabilities. During the first six months of 2020 the Company released $3.0 million of the indemnification asset acquisition related to escrow expirations. The Company has also recorded, as part of the purchase price allocation, deferred tax liabilities related to intangible assets of approximately $25.6 million.

MicroConnex Corporation

On April 1, 2019, the Company acquired 100% of the equity of MicroConnex Corporation ("MicroConnex") for cash consideration of approximately ~~$46.8 million. MicroConnex is a manufacturer~~$46.2 million, including $0.8 million of cash acquired and post-closing adjustments, which were finalized in the third quarter of 2019. The acquired product lines include highly engineered microminiature flex circuits and sensors for the medical and test and measurement markets.

~~MicroConnex~~The product lines contributed revenues of $3.0 million and an operating loss of $0.6 million for the period from April 1, 2019 to June 30, 2019. The results of operations of the acquired business are reported within the CIT segment.

Consideration of $15.2 million has been ~~preliminarily~~ allocated to goodwill, ~~of $15.8 million,~~ $27.4 million to definite-lived intangible assets, $0.9 million to inventory, $3.4 million to accounts receivable, $0.6 million to accounts payable and $7.0 million to deferred income ~~and other taxes payable.~~taxes. Definite-lived intangible assets consist of customer relationships with an ~~estimated~~ useful life of 12 years, trade names with a useful life of 17 years and acquired technologies with a useful life of 5five years. OfNaN of the ~~$15.8~~$15.2 million ofallocated to goodwill ~~none~~ is deductible for tax purposes. All of the goodwill has been ~~preliminarily~~ assigned to the CIT reporting unit, which aligns with the reportable segment.

Note 5—~~Discontinued Operations~~

On March 20, 2018, the Company completed the sale of Carlisle FoodService Products ("CFS") to the Jordan Company of New York, NY, for gross proceeds of $758.0 million, including a working capital adjustment, which was

finalized in the third quarter of 2018. The sale of CFS is consistent with the Company's vision of operating a portfolio of businesses with highly engineered manufacturing products in strong growth markets.

~~A summary of the results from discontinued operations included in the Condensed Consolidated Statements of Income follows:~~

(in millions) Three Months Ended
June 30, 2018 Six Months Ended
June 30, 2018
Revenues $ — $ 69.5
Cost of goods sold — 49.5
Other operating expenses, net 1.0 15.8
Operating (loss) income (1.0) 4.2
Other non-operating (income) expense, net — —
(Loss) income from discontinued operations before income taxes (1.0) 4.2
(Loss) gain on sale of discontinued operations (0.3) 293.5
(Benefit) provision for income taxes (0.3) 47.0
(Loss) income from discontinued operations $ (1.0) $ 250.7

~~Income from discontinued operations of $1.9 million in the six months ended June 30, 2019, relates entirely to the settlement of prior income tax positions in the current year.~~

~~A summary of cash flows from discontinued operations included in the Condensed Consolidated Statements of Cash Flows for the six months ended June 30, follows:~~

~~(in millions)~~

~~2018~~

~~Net cash used in operating activities~~

~~(1.5)~~

~~Net cash used in investing activities~~

~~(8.1)~~

~~Net cash provided by financing activities~~¹

~~10.9~~

~~Change in cash and cash equivalents from discontinued operations~~

~~1.3~~

^1.~~Represents borrowings from the Carlisle cash pool to fund capital expenditures and acquisitions.~~

~~Note 6—~~Earnings Per Share

The Company’s restricted shares contain non-forfeitable rights to dividends and are considered participating securities for purposes of computing earnings per share pursuant to the two-class method. The computation below

of earnings per share excludes ~~the~~ income attributable to the unvested restricted shares infrom the numerator and excludes the dilutive impact of those underlying shares infrom the denominator.

The computation below of earnings per share includes the income attributable to the vested and deferred restricted shares and restricted stock units in the numerator and includes the dilutive impact of those underlying shares in ~~the~~ the denominator.

Stock options are included in the calculation of diluted earnings per share utilizing the treasury stock method and performance share awards are included in the calculation of diluted earnings per share considering those are contingently issuable. Neither is considered to be a participating security as they do not contain non-forfeitable dividend rights.

Income from continuing operations and share data used in the basic and diluted earnings per share computations using the two-class method follows:


		Three Months Ended June 30,									Six Months Ended June 30,										Three Months Ended June 30,						Six Months Ended June 30,
(in millions, except share and per share amounts)		2019			2018			2019			2018
(in millions, except per share amounts)														(in millions, except per share amounts)	2020			2019			2020			2019
Income from continuing operations	Income from continuing operations	$	153.0		$	114.7		$	230.4		$	172.6		Income from continuing operations	$	75.4		$	153.0		$	137.2		$	230.4
Less: dividends declared	Less: dividends declared	(22.9)			(22.5)			(46.2)			(45.6)			Less: dividends declared	(27.7)			(22.9)			(56.0)			(46.2)
Undistributed earnings	Undistributed earnings	130.1			92.2			184.2			127.0			Undistributed earnings	47.7			130.1			81.2			184.2
Percent allocated to common shareholders¹		99.7		%	99.3		%	99.7		%	99.4		%
Percent allocated to common shareholders⁽¹⁾														Percent allocated to common shareholders⁽¹⁾	99.7		%	99.7		%	99.7		%	99.7		%
		129.7			91.6			183.6			126.2				47.6			129.7			81.0			183.6
Add: dividends declared on common stock, restricted share units and vested and deferred restricted and performance shares	Add: dividends declared on common stock, restricted share units and vested and deferred restricted and performance shares	22.9			22.4			46.1			45.2			Add: dividends declared on common stock, restricted share units and vested and deferred restricted and performance shares	27.7			22.9			55.9			46.1
Income from continuing operations attributable to common shares	Income from continuing operations attributable to common shares	$	152.6		$	114.0		$	229.7		$	171.4		Income from continuing operations attributable to common shares	$	75.3		$	152.6		$	136.9		$	229.7

Shares (in thousands):
Shares:														Shares:
Basic weighted-average shares outstanding	Basic weighted-average shares outstanding	56,960			60,641			57,246			61,159			Basic weighted-average shares outstanding	54.8			57.0			55.3			57.2
Effect of dilutive securities:	Effect of dilutive securities:													Effect of dilutive securities:
Performance awards	Performance awards	192			103			172			103			Performance awards	0.2			0.2			0.2			0.2
Stock options	Stock options	414			315			312			331			Stock options	0.2			0.4			0.3			0.3
Diluted weighted-average shares outstanding	Diluted weighted-average shares outstanding	57,566			61,059			57,730			61,593			Diluted weighted-average shares outstanding	55.2			57.6			55.8			57.7

Per share income from continuing operations attributable to common shares:	Per share income from continuing operations attributable to common shares:													Per share income from continuing operations attributable to common shares:
Basic	Basic	$	2.68		$	1.88		$	4.01		$	2.80		Basic	$	1.37		$	2.68		$	2.47		$	4.01
Diluted	Diluted	$	2.65		$	1.87		$	3.98		$	2.78		Diluted	$	1.36		$	2.65		$	2.45		$	3.98

^1. Basic weighted-average common shares outstanding (in thousands)		56,960			60,641			57,246			61,159
Basic weighted-average shares outstanding and unvested restricted shares expected to vest (in thousands)		57,145			61,038			57,431			61,556
⁽¹⁾ Basic weighted-average common shares outstanding														⁽¹⁾ Basic weighted-average common shares outstanding	54.8			57.0			55.3			57.2
Basic weighted-average shares outstanding and unvested restricted shares expected to vest														Basic weighted-average shares outstanding and unvested restricted shares expected to vest	55.0			57.1			55.5			57.4
Percent allocated to common shareholders	Percent allocated to common shareholders	99.7		%	99.3		%	99.7		%	99.4		%	Percent allocated to common shareholders	99.7		%	99.7		%	99.7		%	99.7		%

To calculate earnings per share for income from discontinued operations and for net income, the denominator for both basic and diluted earnings per share is the same as used in the above table.

Three Months Ended
June 30, Six Months Ended
June 30,
(in millions, except share amounts presented in thousands) 2019 2018 2019 2018
(Loss) income from discontinued operations attributable to common shareholders for basic and diluted earnings per share $ (0.1) $ (0.9) $ 1.9 $ 249.1
Net income attributable to common shareholders for basic and diluted earnings per share 152.5 113.0 231.6 420.4
Anti-dilutive stock options excluded from EPS calculation¹
2 711 358 644


	Three Months Ended June 30,						Six Months Ended June 30,
(in millions)	2020		2019		2020		2019
Income from discontinued operations attributable to common shareholders for basic and diluted earnings per share	$	—	$	(0.1)	$	—	$	1.9
Net income attributable to common shareholders for basic and diluted earnings per share	75.3		152.5		136.9		231.6
Anti-dilutive stock options excluded from EPS calculation⁽¹⁾	0.5		—		0.3		0.4

^1.(1)Represents stock options excluded from the calculation of diluted earnings per share, as such options’ assumed proceeds upon exercise would result in the repurchase of more shares than the underlying award.

Note 7—6—Revenue Recognition

The Company receives payment at the inception of the contract for separately priced extended service warranties, and revenue is deferred and recognized on a straight-line basis over the life of the contracts. Remaining performance obligations for extended service warranties represent the transaction price for the remaining stand-ready obligation to perform warranty services. A summary of estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied or partially unsatisfied as of June 30, ~~2019,~~2020, follows:

(in millions) Remainder of 2019 2020 2021 2022 2023 2024 Thereafter
Extended service warranties $ 10.7 $ 20.6 $ 19.6 $ 18.4 $ 17.2 $ 16.1 $ 126.7


(in millions)	Remainder of 2020		2021		2022		2023		2024		2025		Thereafter
Extended service warranties	$	11.4	$	21.8	$	20.6	$	19.4	$	18.3	$	17.4	$	140.0

The Company has applied the practical expedient to not disclose information about remaining performance obligations that have original expected durations of one year or less.

Contract Balances

Contract liabilities relate to payments received in advance of performance under a contract and primarily include extended service warranties in the CCM segment, ~~and~~ systems contracts in the CFT segment, and highly customized product contracts within the CIT segment. Contract liabilities are recognized as revenue as (or when) the Company performs under the contract. A summary of the change in contract liabilities for the six months ended June 30, follows:


(in millions)	(in millions)	2019		2018		(in millions)	2020		2019
Balance as of January 1	Balance as of January 1	$	227.4	$	215.8	Balance as of January 1	$	247.4	$	227.4
Revenue recognized	Revenue recognized	(30.2)		(31.2)		Revenue recognized	(28.8)		(30.2)
Revenue deferred	Revenue deferred	35.3		39.6		Revenue deferred	40.2		35.3
Acquired liabilities	Acquired liabilities	2.7		0.2		Acquired liabilities	—		2.7
Balance as of June 30	Balance as of June 30	$	235.2	$	224.4	Balance as of June 30	$	258.8	$	235.2

Contract assets relate to the Company's right to payment for performance completed to date under a contract and primarily include highly customized product contracts within the CIT segment and systems contracts in the CFT segment. Accounts receivable are recorded when the right to payment becomes unconditional. A summary of the change in contract assets for the six months ended June 30, follows:


(in millions)	(in millions)	2019		2018		(in millions)	2020		2019
Balance as of January 1	Balance as of January 1	$	44.7	$	—	Balance as of January 1	$	100.5	$	44.7
Adoption of ASC 606		—		22.8
Revenue recognized and unbilled		116.3		69.5
Revenue billed		(102.9)		(49.5)
Balance as of June 30	Balance as of June 30	$	58.1	$	42.8	Balance as of June 30	101.9		58.1
Change in contract assets						Change in contract assets	$	1.4	$	13.4

Revenues by End-Market

A summary of revenues disaggregated by major end-market industries and reconciliation of disaggregated revenue by segment follows:

Three Months Ended June 30, 2019
(in millions) CCM CIT CFT CBF Total
General construction $ 860.5 $ — $ — $ — $ 860.5
Aerospace — 164.6 — 5.7 170.3
Heavy equipment 28.2 — — 69.5 97.7
Transportation — — 36.4 8.4 44.8
Medical — 37.6 — — 37.6
General industrial and other 26.3 43.2 30.9 3.5 103.9
Total revenues $ 915.0 $ 245.4 $ 67.3 $ 87.1 $ 1,314.8
Three Months Ended June 30, 2018
(in millions) CCM CIT CFT CBF Total
General construction $ 768.1 $ — $ — $ — $ 768.1
Aerospace — 150.8 — 3.5 154.3
Heavy equipment 31.6 — — 79.3 110.9
Transportation — — 39.9 11.5 51.4
Medical — 34.6 — — 34.6
General industrial and other 28.9 52.3 33.4 2.2 116.8
Total revenues $ 828.6 $ 237.7 $ 73.3 $ 96.5 $ 1,236.1


	Three Months Ended June 30, 2020
(in millions)	CCM		CIT		CFT		CBF		Total
General construction	$	699.2	$	—	$	—	$	—	$	699.2
Aerospace	—		80.8		—		2.9		83.7
Heavy equipment	14.0		—		—		48.5		62.5
Transportation	—		—		23.2		5.2		28.4
Medical	—		62.8		—		—		62.8
General industrial and other	21.7		40.4		23.3		2.2		87.6
Total revenues	$	734.9	$	184.0	$	46.5	$	58.8	$	1,024.2

	Three Months Ended June 30, 2019
(in millions)	CCM		CIT		CFT		CBF		Total
General construction	$	860.5	$	—	$	—	$	—	$	860.5
Aerospace	—		164.6		—		5.7		170.3
Heavy equipment	28.2		—		—		69.5		97.7
Transportation	—		—		36.4		8.4		44.8
Medical	—		37.6		—		—		37.6
General industrial and other	26.3		43.2		30.9		3.5		103.9
Total revenues	$	915.0	$	245.4	$	67.3	$	87.1	$	1,314.8


	Six Months Ended June 30, 2020
(in millions)	CCM		CIT		CFT		CBF		Total
General construction	$	1,335.0	$	—	$	—	$	—	$	1,335.0
Aerospace	—		217.5		—		8.8		226.3
Heavy equipment	35.5		—		—		102.6		138.1
Transportation	—		—		58.5		13.4		71.9
Medical	—		111.0		—		—		111.0
General industrial and other	40.8		80.0		46.3		5.0		172.1
Total revenues	$	1,411.3	$	408.5	$	104.8	$	129.8	$	2,054.4

	Six Months Ended June 30, 2019
(in millions)	CCM		CIT		CFT		CBF		Total
General construction	$	1,482.1	$	—	$	—	$	—	$	1,482.1
Aerospace	—		338.4		—		10.3		348.7
Heavy equipment	55.4		—		—		144.7		200.1
Transportation	—		—		68.7		17.6		86.3
Medical	—		68.6		—		—		68.6
General industrial and other	48.6		84.8		61.7		5.8		200.9
Total revenues	$	1,586.1	$	491.8	$	130.4	$	178.4	$	2,386.7

1314

Six Months Ended June 30, 2019
(in millions) CCM CIT CFT CBF Total
General construction $ 1,482.1 $ — $ — $ — $ 1,482.1
Aerospace — 338.4 — 10.3 348.7
Heavy equipment 55.4 — — 144.7 200.1
Transportation — — 68.7 17.6 86.3
Medical — 68.6 — — 68.6
General industrial and other 48.6 84.8 61.7 5.8 200.9
Total revenues $ 1,586.1 $ 491.8 $ 130.4 $ 178.4 $ 2,386.7
Six Months Ended June 30, 2018
(in millions) CCM CIT CFT CBF Total
General construction $ 1,314.4 $ — $ — $ — $ 1,314.4
Aerospace — 305.6 — 9.8 315.4
Heavy equipment 57.8 — — 158.5 216.3
Transportation — — 73.1 21.3 94.4
Medical — 69.3 — — 69.3
General industrial and other 55.0 87.1 63.7 5.2 211.0
Total revenues $ 1,427.2 $ 462.0 $ 136.8 $ 194.8 $ 2,220.8

Revenues by Geographic Area

A summary of revenues based on the country to which the product was delivered and reconciliation of disaggregated revenue by segment follows:


	Three Months Ended June 30, 2020
(in millions)	CCM		CIT		CFT		CBF		Total
United States	$	657.2	$	129.3	$	20.7	$	22.2	$	829.4
International:
Europe	51.3		20.7		6.4		16.9		95.3
Asia	4.8		18.6		17.4		14.6		55.4
Canada	17.4		0.7		0.8		1.1		20.0
Mexico and Latin America	0.8		5.4		0.8		1.5		8.5
Middle East and Africa	2.4		2.4		0.2		0.2		5.2
Other	1.0		6.9		0.2		2.3		10.4
Total international	77.7		54.7		25.8		36.6		194.8
Total revenues	$	734.9	$	184.0	$	46.5	$	58.8	$	1,024.2

	Three Months Ended June 30, 2019
(in millions)	CCM		CIT		CFT		CBF		Total
United States	$	824.6	$	171.4	$	31.7	$	34.1	$	1,061.8
International:
Europe	55.2		17.9		12.4		27.0		112.5
Asia	5.6		33.8		21.3		18.3		79.0
Canada	25.0		1.3		1.0		1.3		28.6
Mexico and Latin America	0.8		13.3		0.2		2.7		17.0
Middle East and Africa	2.0		6.2		0.4		0.2		8.8
Other	1.8		1.5		0.3		3.5		7.1
Total international	90.4		74.0		35.6		53.0		253.0
Total revenues	$	915.0	$	245.4	$	67.3	$	87.1	$	1,314.8

Three Months Ended June 30, 2019
(in millions) CCM CIT CFT CBF Total
United States $ 824.6 $ 171.4 $ 31.7 $ 34.1 $ 1,061.8
International:
Europe 55.2 17.9 12.4 27.0 112.5
Asia 5.6 33.8 21.3 18.3 79.0
Canada 25.0 1.3 1.0 1.3 28.6
Mexico 0.8 13.3 0.2 2.7 17.0
Middle East and Africa 2.0 6.2 0.4 0.2 8.8
Other 1.8 1.5 0.3 3.5 7.1
Total international 90.4 74.0 35.6 53.0 253.0
Total revenues $ 915.0 $ 245.4 $ 67.3 $ 87.1 $ 1,314.8
Three Months Ended June 30, 2018
(in millions) CCM CIT CFT CBF Total
United States $ 733.6 $ 164.7 $ 30.7 $ 38.7 $ 967.7
International:
Europe 52.4 23.0 15.0 28.9 119.3
Asia 3.6 25.6 24.6 20.6 74.4
Canada 29.5 1.4 1.7 0.7 33.3
Mexico 1.4 12.4 0.5 3.9 18.2
Middle East and Africa 5.8 6.7 0.8 0.3 13.6
Other 2.3 3.9 — 3.4 9.6
Total international 95.0 73.0 42.6 57.8 268.4
Total revenues $ 828.6 $ 237.7 $ 73.3 $ 96.5 $ 1,236.1

1415


		Six Months Ended June 30, 2019																			Six Months Ended June 30, 2020
(in millions)	(in millions)	CCM		CIT		CFT		CBF		Total		(in millions)	CCM		CIT		CFT		CBF		Total
United States	United States	$	1,415.8	$	353.5	$	59.7	$	66.6	$	1,895.6	United States	$	1,254.1	$	290.7	$	49.0	$	52.9	$	1,646.7
International:	International:											International:
Europe	Europe	107.3		36.3		25.5		57.5		226.6		Europe	102.4		40.0		16.8		36.3		195.5
Asia	Asia	9.7		57.6		40.3		38.7		146.3		Asia	8.1		37.0		34.3		29.7		109.1
Canada	Canada	42.5		2.4		2.6		1.8		49.3		Canada	35.8		1.9		2.2		1.7		41.6
Mexico	Mexico	1.2		25.7		0.7		6.0		33.6		Mexico	2.0		16.6		1.4		3.8		23.8
Middle East and Africa	Middle East and Africa	5.4		13.5		1.0		0.6		20.5		Middle East and Africa	6.3		7.3		0.7		0.4		14.7
Other	Other	4.2		2.8		0.6		7.2		14.8		Other	2.6		15.0		0.4		5.0		23.0
Total international	Total international	170.3		138.3		70.7		111.8		491.1		Total international	157.2		117.8		55.8		76.9		407.7
Total revenues	Total revenues	$	1,586.1	$	491.8	$	130.4	$	178.4	$	2,386.7	Total revenues	$	1,411.3	$	408.5	$	104.8	$	129.8	$	2,054.4

		Six Months Ended June 30, 2018																			Six Months Ended June 30, 2019
(in millions)	(in millions)	CCM		CIT		CFT		CBF		Total		(in millions)	CCM		CIT		CFT		CBF		Total
United States	United States	$	1,262.6	$	320.3	$	56.3	$	80.2	$	1,719.4	United States	$	1,415.8	$	353.5	$	59.7	$	66.6	$	1,895.6
International:	International:											International:
Europe	Europe	91.8		45.3		28.3		59.2		224.6		Europe	107.3		36.3		25.5		57.5		226.6
Asia	Asia	8.8		48.5		44.4		39.5		141.2		Asia	9.7		57.6		40.3		38.7		146.3
Canada	Canada	47.9		2.5		3.3		1.4		55.1		Canada	42.5		2.4		2.6		1.8		49.3
Mexico	Mexico	2.3		24.4		2.6		7.5		36.8		Mexico	1.2		25.7		0.7		6.0		33.6
Middle East and Africa	Middle East and Africa	8.9		14.3		1.4		0.5		25.1		Middle East and Africa	5.4		13.5		1.0		0.6		20.5
Other	Other	4.9		6.7		0.5		6.5		18.6		Other	4.2		2.8		0.6		7.2		14.8
Total international	Total international	164.6		141.7		80.5		114.6		501.4		Total international	170.3		138.3		70.7		111.8		491.1
Total revenues	Total revenues	$	1,427.2	$	462.0	$	136.8	$	194.8	$	2,220.8	Total revenues	$	1,586.1	$	491.8	$	130.4	$	178.4	$	2,386.7

Note 8—7—Stock-Based Compensation

Stock-based compensation cost by award type follows:

(in millions) Three Months Ended
June 30, Six Months Ended
June 30,
2019 2018 2019 2018
Stock option awards $ 2.5 $ 2.3 $ 5.6 $ 4.3
Restricted stock awards 2.1 2.3 4.1 4.2
Performance share awards 1.5 2.5 3.1 4.2
Restricted stock units — 0.1 1.3 1.5
Stock appreciation rights 2.1 — 2.9 —
Total stock-based compensation cost $ 8.2 $ 7.2 $ 17.0 $ 14.2

In 2018, the Board authorized a grant of stock options to U.S. employees and stock appreciation rights to employees outside of the U.S. This grant contributed $2.7 million and $4.5 million to stock-based compensation cost for the three and six months ended June 30, 2019, respectively. As of June 30, 2019, compensation cost of $1.7 million was capitalized as inventory and will be recognized in costs of goods sold when that related inventory is sold.


(in millions)	Three Months Ended June 30,									Six Months Ended June 30,
			2020			2019			2020			2019
Stock option awards	$	2.6		$	2.5		$	5.8		$	5.6
Restricted stock awards	1.9			2.1			4.0			4.1
Performance share awards	1.7			1.5			3.8			3.1
Restricted stock units	—			—			1.4			1.3
Stock appreciation rights	(0.3)			2.1			(3.9)			2.9
Total stock-based compensation cost incurred	5.9			8.2			11.1			17.0
Capitalized credit (cost) during the period	0.1			(2.6)			3.4			(3.8)
Amortization of capitalized (credit) cost during the period	(3.8)			1.7			0.4			2.3
Total stock-based compensation expense	$	2.2		$	7.3		$	14.9		$	15.5

Note 9—8—Exit and Disposal and Other Restructuring Activities

The Company has undertaken operational restructuring and other cost reduction actions to streamline processes and manage costs throughout various departments. These actions resulted in exit, disposal and employee termination benefit costs, primarily resulting from planned reductions in workforce, facility ~~consolidations~~consolidation and ~~relocations,~~relocation, and lease termination costs. The primary actions are discussed below by operating segment.

CIT

During the second quarter of 2020, the Company initiated plans to exit its manufacturing operations in Mobile, Alabama, and relocate the majority of those operations to its existing manufacturing facility in Franklin, Wisconsin. This project is substantially complete with cumulative exit and disposal costs of $1.4 million, primarily for employee termination benefit costs and the impairment of certain assets, recognized through June 30, 2020.

1516

~~CIT~~

~~During 2019, the~~The Company ~~announced plans~~is substantially complete with its project to relocate its aerospace connectors manufacturing operations in El Segundo, California, and Riverside, California, to existing ~~manufacturing~~lower cost operations in North America. During the three and six months ended June 30, ~~2019,~~2020, exit and disposal costs totaled ~~$0.9~~$0.4 million and ~~$4.4~~$2.3 million, respectively, primarily for facility clean up, travel and employee termination benefit costs. ~~The project is estimated to take 12 to 18 months to complete.~~ Cumulative exit and disposal costs ~~are expected to approximate $7.4~~of $10.9 million ~~with approximately $2.5 million costs remaining to be incurred, primarily in 2019.~~were recognized through June 30, 2020.

~~CFT~~CBF

During the first quarter of ~~2019,~~2020, the Company initiated plans to consolidate certain operations globally to reduce costs and streamline processes by ~~eliminating~~consolidating certain positions within selling, general and administrative, and manufacturing ~~functions. The costs to complete this project totaled $2.1 million~~functions, and ~~were recognized primarily~~exited less profitable product lines that resulted in ~~the first quarter of 2019.~~

~~CBF~~

The Company is substantially complete with its project to exit its manufacturing operations in Tulsa, Oklahoma, and relocate the majority of those operations to its existing manufacturing facility in Medina, Ohio.asset write-offs. During the three and six months ended June 30, ~~2019,~~2020, exit and disposal costs totaled ~~$0.5~~$1.4 million and ~~$1.2~~$4.2 million, ~~respectively, primarily reflecting facility closure costs and employee termination benefits.~~respectively. Total associated exit and disposal costs are expected to approximate ~~$20.9~~$5.8 million, with ~~cumulative exit and disposal~~approximately $1.6 million of costs ~~of $19.9 million recognized as of June 30, 2019. Remaining costs of approximately $1.0 million are expected~~remaining to be incurred ~~throughout~~in the ~~remainder~~second half of ~~2019.~~2020.

Other Actions

The Company implemented restructuring activities to reduce its overall headcount as a result of general market declines from the coronavirus global pandemic ("COVID-19"). These actions resulted in severance payments of $2.8 million and $2.1 million at CIT and CFT, respectively, during the three months ended June 30, 2020. CCM incurred $0.2 million and $0.3 million in severance payments for the three and six months ended June 30, 2020, respectively.

Consolidated Summary

The Company's exit and disposal costs by activity follows:


(in millions)	(in millions)	Three Months Ended June 30,									Six Months Ended June 30,							(in millions)	Three Months Ended June 30,					Six Months Ended June 30,
				2019			2018			2019			2018	(in millions)			2020		2019		2020		2019
Employee severance and benefit arrangements	Employee severance and benefit arrangements	$	0.4		$	1.0		$	6.1		$	1.7	Employee severance and benefit arrangements		$	6.5	$	0.4	$	8.4	$	6.1
Lease termination cost		0.4			—			0.9			—
Accelerated depreciation and impairments													Accelerated depreciation and impairments		1.0		—		2.2		—
Facility cleanup costs													Facility cleanup costs		—		—		0.8		—
Relocation costs	Relocation costs	—			0.2			0.1			0.4		Relocation costs		0.1		—		0.3		0.1
Accelerated depreciation		—			0.3			—			1.1
Lease termination costs													Lease termination costs		—		0.4		—		0.9
Other restructuring costs	Other restructuring costs	0.7			3.1			1.2			4.5		Other restructuring costs		0.7		0.7		1.4		1.2
Total exit and disposal costs	Total exit and disposal costs	$	1.5		$	4.6		$	8.3		$	7.7	Total exit and disposal costs		$	8.3	$	1.5	$	13.1	$	8.3

The Company's exit and disposal costs by segment follows:


(in millions)	(in millions)	Three Months Ended June 30,									Six Months Ended June 30,							(in millions)	Three Months Ended June 30,					Six Months Ended June 30,
				2019			2018			2019			2018	(in millions)			2020		2019		2020		2019
Carlisle Interconnect Technologies	Carlisle Interconnect Technologies	$	0.9		$	0.8		$	4.8		$	1.9	Carlisle Interconnect Technologies		$	4.6	$	0.9	$	6.5	$	4.8
Carlisle Brake & Friction													Carlisle Brake & Friction		1.4		0.5		4.2		1.2
Carlisle Fluid Technologies	Carlisle Fluid Technologies	0.1			0.5			2.1			0.5		Carlisle Fluid Technologies		2.1		0.1		2.1		2.1
Carlisle Brake & Friction		0.5			3.3			1.2			5.3
Carlisle Construction Materials	Carlisle Construction Materials	—			—			0.2			—		Carlisle Construction Materials		0.2		—		0.3		0.2

Total exit and disposal costs	Total exit and disposal costs	$	1.5		$	4.6		$	8.3		$	7.7	Total exit and disposal costs		$	8.3	$	1.5	$	13.1	$	8.3

The Company's exit and disposal costs by financial statement line item follows:


(in millions)	(in millions)	Three Months Ended June 30,									Six Months Ended June 30,							(in millions)	Three Months Ended June 30,					Six Months Ended June 30,
				2019			2018			2019			2018	(in millions)			2020		2019		2020		2019
Cost of goods sold	Cost of goods sold	$	0.9		$	3.7		$	4.5		$	6.0	Cost of goods sold		$	3.1	$	0.9	$	6.1	$	4.5
Selling and administrative expenses	Selling and administrative expenses	0.6			0.7			3.5			1.3		Selling and administrative expenses		3.6		0.6		5.2		3.5
Research and development expenses													Research and development expenses		—		—		—		0.1
Other operating expense, net	Other operating expense, net	—			0.2			0.2			0.4		Other operating expense, net		1.6		—		1.8		0.2
Research and development expenses		—			—			0.1			—
Total exit and disposal costs	Total exit and disposal costs	$	1.5		$	4.6		$	8.3		$	7.7	Total exit and disposal costs		$	8.3	$	1.5	$	13.1	$	8.3

1617

The Company's change in exit and disposal activities liability follows:

(in millions)

Total

Balance as of December 31, ~~2018~~2019

~~1.2~~5.2

Charges

~~8.3~~13.1

Cash payments

~~(4.4)~~(15.1)

Balance as of June 30, ~~2019~~2020

~~5.1~~3.2

The liability of ~~$5.1~~$3.2 million primarily relates to employee severance and benefit arrangements and is included in accrued ~~liabilities~~ and ~~other.~~other current liabilities.

Note ~~10—~~9—Income Taxes

The effective income tax rate on continuing operations for the six months ended June 30, 2020, was 20.8%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 24.0% and a year-to-date net discrete tax benefit of $5.3 million. The year-to-date net discrete tax benefit relates primarily to a reduction of unrecognized income tax benefits of $5.5 million.

The effective income tax rate on continuing operations for the six months ended June 30, 2019, was 21.8%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 23.7% and a year-to-date net discrete tax benefit of $5.0 million. The year-to-date net discrete tax benefit relates primarily to a reduced tax liability on prior year tax filings finalized in the current quarter of $2.7 million, excess tax benefits related to employee stock compensation of $1.5 million, and a reduction of unrecognized income tax benefits of $1.2 million.

The effective income tax rate on continuing operations for the six months ended June 30, 2018, was 23.1%. The year-to-date provision for income taxes includes taxes on earnings at an anticipated rate of approximately 24.7% and a year-to-date net discrete tax benefit of $3.5 million.

Note ~~11—~~10—Inventories, net


(in millions)	(in millions)	June 30, 2019		December 31, 2018		(in millions)	June 30, 2020		December 31, 2019
Raw materials	Raw materials	$	211.7	$	195.1	Raw materials	$	246.2	$	241.0
Work-in-process	Work-in-process	72.2		59.5		Work-in-process	44.2		45.2
Finished goods	Finished goods	257.3		236.5		Finished goods	298.4		260.9
Reserves	Reserves	(35.6)		(33.6)		Reserves	(41.0)		(36.5)
Inventories, net	Inventories, net	$	505.6	$	457.5	Inventories, net	$	547.8	$	510.6

Note ~~12—~~11—Goodwill and Other Intangible Assets, net

Goodwill

In the second quarter of 2020, changes in facts and circumstances and general market declines from COVID-19 resulted in reduced expectations of future operating results. The Company considered these circumstances and the potential long-term impact on cash flows associated with its reporting units and determined that an indicator of possible impairment existed within its CFT and CBF reporting units. Accordingly, the Company performed a quantitative impairment analysis to determine the fair values of those reporting units. The Company used both an income approach utilizing the discounted cash flow method ("DCF") and a market approach utilizing the public company market multiple method. The key techniques and assumptions used include:


Valuation Technique						Key Assumptions
Discounted future cash flows						•Estimated future revenues •Earnings before interest, taxes, depreciation and amortization ("EBITDA") margins •Discount rates
Market multiple method						•Peer public company group •Financial performance of reporting units relative to peer public company group

Based on the output of the analysis, the Company determined that the fair values of both the CFT and CBF reporting units exceeded their carrying amounts. Accordingly, 0 impairment charges were required as of June 30, 2020.

The changes in the carrying amount of goodwill, net by segment follows:


(in millions)	(in millions)	CCM		CIT		CFT			CBF¹		Total		(in millions)	CCM		CIT		CFT		CBF⁽¹⁾		Total
Balance as of December 31, 2018		$	532.8	$	643.1	$	169.5		$	96.4	$	1,441.8
Goodwill acquired during year²		63.0		15.8		11.3		³	—		90.1
Balance as of December 31, 2019													Balance as of December 31, 2019	$	597.1	$	835.2	$	187.5	$	96.5	$	1,716.3
Goodwill acquired during year⁽²⁾													Goodwill acquired during year⁽²⁾	1.5		—		—		—		1.5

Measurement period adjustments(3)	Measurement period adjustments(3)	0.3		(1.3)		—			—		(1.0)		Measurement period adjustments(3)	—		(5.2)		—		—		(5.2)
Currency translation and other	Currency translation and other	(0.1)		—		0.1			—		—		Currency translation and other	(0.4)		(2.5)		(1.3)		(0.1)		(4.3)
Balance as of June 30, 2019		$	596.0	$	657.6	$	180.9		$	96.4	$	1,530.9
Balance as of June 30, 2020													Balance as of June 30, 2020	$	598.2	$	827.5	$	186.2	$	96.4	$	1,708.3

^1.(1)CBF goodwill, net is presented net of accumulated impairment losses of $130.0 million recorded in 2016. No other segments have incurred impairment losses.

^2.(2)The Company acquired 1 business for an aggregate purchase price of $3.2 million during the first six months of 2020.

⁽³⁾Refer to Note 4 for further information on goodwill resulting from recent acquisitions.

^3.~~During~~Indefinite-Lived Intangible Assets

As noted above, in the ~~first six months~~second quarter of ~~2019,~~2020 changes in facts and circumstances and general market declines from COVID-19 resulted in reduced revenues. The Company considered these circumstances and the potential long-term impact on revenues associated with its trade names and determined that an indicator of possible impairment existed within its CFT and CBF trade names. Accordingly, the Company ~~acquired two businesses for~~performed a quantitative impairment analysis to determine the fair values of its CFT and CBF indefinite-lived trade names using an ~~aggregate purchase price~~income approach, commonly known as the relief from royalty method. Key assumptions made by management in developing the inputs to the associated model include growth rates, expected royalty rates, discount rates and tax rates.

Based on the output of ~~$24.7 million.~~

the analysis, the Company determined that the fair values of both the CFT and CBF indefinite-lived trade names exceeded their carrying amounts. Accordingly, 0 impairment charges were required as of June 30, 2020.

A summary of the Company's other intangible assets, net follows:

June 30, 2019 December 31, 2018
(in millions)
Acquired
Cost
Accumulated
Amortization
Net Book Value
Acquired
Cost
Accumulated
Amortization
Net Book Value
Assets subject to amortization:
Customer relationships $ 944.2 $ (321.8) $ 622.4 $ 843.8 $ (287.7) $ 556.1
Technology and intellectual property 285.8 (146.1) 139.7 268.8 (129.3) 139.5
Trade names and other 73.9 (20.4) 53.5 45.4 (16.4) 29.0
Assets not subject to amortization:
Trade names 243.0 — 243.0 243.1 — 243.1
Other intangible assets, net $ 1,546.9 $ (488.3) $ 1,058.6 $ 1,401.1 $ (433.4) $ 967.7


	June 30, 2020										December 31, 2019
(in millions)	Acquired Cost		Accumulated Amortization		Net Book Value		Acquired Cost		Accumulated Amortization		Net Book Value
Assets subject to amortization:
Customer relationships	$	1,048.8	$	(392.8)	$	656.0	$	1,054.4	$	(354.9)	$	699.5
Technology and intellectual property	304.1		(185.8)		118.3		304.1		(167.0)		137.1
Trade names and other	111.5		(44.4)		67.1		100.0		(38.7)		61.3
Assets not subject to amortization:
Trade names	242.5		—		242.5		242.7		—		242.7
Other intangible assets, net	$	1,706.9	$	(623.0)	$	1,083.9	$	1,701.2	$	(560.6)	$	1,140.6

The net book values of other intangible assets, net by reportable segment follows:


(in millions)	(in millions)	June 30, 2019		December 31, 2018		(in millions)	June 30, 2020		December 31, 2019
Carlisle Construction Materials	Carlisle Construction Materials	$	370.1	$	285.3	Carlisle Construction Materials	$	321.5	$	345.3
Carlisle Interconnect Technologies	Carlisle Interconnect Technologies	322.3		313.4		Carlisle Interconnect Technologies	413.1		441.0
Carlisle Fluid Technologies	Carlisle Fluid Technologies	281.3		280.9		Carlisle Fluid Technologies	262.3		272.8
Carlisle Brake & Friction	Carlisle Brake & Friction	83.4		86.6		Carlisle Brake & Friction	77.1		80.2
Corporate	Corporate	1.5		1.5		Corporate	9.9		1.3
Total	Total	$	1,058.6	$	967.7	Total	$	1,083.9	$	1,140.6

~~Note 13—Leases~~

The Company determines if an arrangement is a lease at inception by evaluating if the asset is explicitly or implicitly identified or distinct, if the Company will receive substantially all of the economic benefit or if the lessor has an economic benefit and the ability to substitute the asset. Operating leases are included in other long-term assets, accrued liabilities and other, and other long-term liabilities.

ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of fixed and known lease payments over the lease term. Variable payments are not included in the ROU asset or lease liability and can vary from period to period based on the use of an asset during the period or the Company's proportionate share of common costs. As most of the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and lease expense for these leases is recognized on a straight-line basis over the lease term.

The Company has lease agreements with lease components and non-lease components. The Company has elected to apply the practical expedient to account for these components as a single lease component, for all classes of underlying assets.

~~Lease Costs, Assets and Liabilities~~

~~The Company has operating leases primarily for manufacturing facilities, warehouses, offices and certain equipment. These leases have remaining lease terms of~~ ~~one~~ ~~to 13 years, some of which include one or more options to renew, with renewal terms that can extend the leases to~~ ~~one~~ ~~or 20 years or more. The components of lease cost follow:~~

(in millions) Three Months Ended
June 30, 2019 Six Months Ended
June 30, 2019
Operating lease cost $ 6.8 $ 13.2
Variable lease cost 1.8 3.3
Short-term lease cost 0.8 1.5
Total lease cost $ 9.4 $ 18.0

~~A summary of lease assets and liabilities follows:~~

~~(in millions)~~

June 30,
2019

~~Assets:~~

~~Operating lease right-of-use assets~~¹

~~79.0~~

~~Liabilities:~~

~~Operating lease liabilities - current~~²

~~21.6~~

~~Operating lease liabilities - long-term~~³

~~63.3~~

~~Total lease liabilities~~

~~84.9~~

^1.~~Included in other long-term assets.~~

^2.~~Included in accrued liabilities and other.~~

^3.~~Included in other long-term liabilities.~~

~~Maturity of lease liabilities as of June 30, 2019, follow:~~

(in millions) Remainder of 2019 2020 2021 2022 2023 2024 Thereafter Total
Lease payments $ 13.5 $ 20.2 $ 15.0 $ 11.1 $ 8.6 $ 6.4 $ 22.9 $ 97.7
Less: imputed interest (12.8)
Total lease liabilities $ 84.9

As previously disclosed in our 2018 Annual Report on Form 10-K and under the previous lease accounting standard, future minimum lease payments for non-cancelable operating leases in future years would have been as follows:

(in millions) 2019 2020 2021 2022 2023 Thereafter
Future minimum lease payments $ 16.7 $ 10.8 $ 6.8 $ 4.9 $ 4.2 $ 5.1

~~Lease Term and Discount Rate~~


	June 30, 2019
~~Operating leases:~~
~~Weighted-average remaining lease term (in years)~~	~~6.6~~
~~Weighted-average discount rate~~	~~3.9~~	%

~~Supplemental Cash Flow Information~~

Cash paid for amounts included in the measurement of operating lease liabilities totaled $13.4 million for the six months ended June 30, 2019. Operating lease right-of-use assets obtained in exchange for new operating lease liabilities totaled $87.4 million for the six months ended June 30, 2019, of which $69.1 million related to the adoption of ASC 842.

Note ~~14—~~12—Long-term Debt


(in millions)	(in millions)							Fair Value¹								(in millions)					Fair Value⁽¹⁾
				June 30, 2019			December 31, 2018			June 30, 2019			December 31, 2018	(in millions)			June 30, 2020		December 31, 2019		June 30, 2020		December 31, 2019
2.75% Notes due 2030													2.75% Notes due 2030		$	750.0	$	—	$	768.2	$	—
3.75% Notes due 2027	3.75% Notes due 2027	$	600.0		$	600.0		$	609.5		$	579.4	3.75% Notes due 2027		600.0		600.0		658.8		623.4
3.5% Notes due 2024	3.5% Notes due 2024	400.0			400.0			407.4			386.4		3.5% Notes due 2024		400.0		400.0		427.0		414.2
3.75% Notes due 2022	3.75% Notes due 2022	350.0			350.0			358.7			345.5		3.75% Notes due 2022		350.0		350.0		366.6		361.4
5.125% Notes due 2020	5.125% Notes due 2020	250.0			250.0			256.9			255.0		5.125% Notes due 2020		—		250.0		—		255.0

Unamortized discount, debt issuance costs, and other		(7.8)			(12.2)
Unamortized discount, debt issuance costs and other													Unamortized discount, debt issuance costs and other		(22.0)		(8.4)
Total long term-debt	Total long term-debt	1,592.2			1,587.8								Total long term-debt		2,078.0		1,591.6
Less: current portion of long-term debt	Less: current portion of long-term debt	2.8			—								Less: current portion of long-term debt		0.8		250.2
Total long term-debt, net of current portion	Total long term-debt, net of current portion	$	1,589.4		$	1,587.8							Total long term-debt, net of current portion		$	2,077.2	$	1,341.4

^1.(1)The fair value is estimated based on current yield rates plus the Company’s estimated credit spread available for financings with similar terms and maturities. Based on these inputs, the debt instruments are classified as Level 2 in the fair value hierarchy.

2.75% Notes Due 2030

On February 28, 2020, the Company completed a public offering of $750.0 million of notes with a stated interest rate of 2.75% due March 1, 2030 (the “2030 Notes”). The 2030 Notes were issued at a discount of $9.3 million, resulting in proceeds to the Company of $740.7 million. The Company incurred costs, primarily underwriting fees, to issue the 2030 Notes of approximately $6.5 million. Additionally in the first quarter of 2020, the Company entered into interest rate derivative instruments to hedge variability in future interest payments on the 2030 Notes of the 10-year US Treasury Rate ("treasury locks"), which were designated as hedges, and settled resulting in a loss of $16.4 million. The discount and issuance costs of $15.8 million are reflected net within long-term debt on the Condensed Consolidated Balance Sheets and the loss on treasury locks of $16.4 million is reflected in accumulated other comprehensive income on the Condensed Consolidated Balance Sheets. These costs are amortized to interest expense over the life of the 2030 Notes using the effective interest method. Interest is paid each March 1 and September 1, commencing on September 1, 2020.

Repayment of 5.125% Notes Due 2020

On February 28, 2020, the Company issued a notice for the redemption in full of the $250.0 million aggregate principal amount of its outstanding 5.125% notes due December 15, 2020 (the “2020 Notes”). The 2020 Notes were redeemed on March 29, 2020 (the “Redemption Date”) at the redemption price of $262.1 million, consisting of the principal amount of $250.0 million, $8.4 million premium for early redemption and $3.7 million of interest to the redemption date. The premium along with remaining unamortized issuance costs of $8.8 million are reflected in loss on extinguishment of debt and the $3.7 million of interest is reflected in interest expense in the Condensed Consolidated Statements of Income in the first quarter of 2020.

Revolving Credit Facility (the “Facility”)

On February 5, 2020, the Company entered into the Company's Fourth Amended and Restated Credit Agreement (the “Amendment”) administered by JPMorgan Chase Bank, N.A. Among other things, the Amendment extended the maturity date of the Facility from February 21, 2022, to February 5, 2025. During the first quarter of 2020, the Company incurred $1.3 million of financing costs to finalize the amendment, which are recognized ratably over the extended maturity date of the Facility. The Facility has a feature that allows the Company to increase availability, at our option, by an aggregate amount of up to $500.0 million through increased commitments from existing lenders or the addition of new lenders. Under the Facility the Company may also enter into commitments in the form of standby, commercial, or direct pay letters of credit for an amount not to exceed $50.0 million. The Facility provides for grid-based interest pricing based on the credit rating of the senior unsecured bank debt or other unsecured senior debt. The Facility is also subject to fees based on applicable rates as defined in the agreement and the aggregate commitment, regardless of usage.

During the six months ended June 30, ~~2019, there were no~~2020, borrowings orand repayments under the ~~Facility.~~Facility totaled $500.0 million with a weighted average interest rate of 1.9%. As of June 30, ~~2019~~2020 and December 31, ~~2018,~~2019, the Facility had no0 outstanding balance and $1.0 billion available for use.

Covenants and Limitations

Under the Company’s debt and credit facilities, the Company is required to meet various restrictive covenants and limitations, including limitations on certain leverage ratios, interest coverage, and limits on outstanding debt balances held by certain subsidiaries. The Company was in compliance with all covenants and limitations as of June 30, ~~2019~~2020 and December 31, ~~2018.~~ 2019.

Letters of Credit and Guarantees

During the normal course of business, the Company enters into commitments in the form of letters of credit and bank guarantees to provide financial and performance assurance to third parties. As of June 30, ~~2019~~2020 and December 31, ~~2018,~~2019, the Company had ~~$26.1~~$26.0 million and ~~$26.0~~$25.5 million, in letters of credit and bank guarantees outstanding, respectively. The Company has multiple arrangements to obtain letters of credit, which include an agreement with unspecified availability and separate agreements for up to $80.0 million in letters of credit, of which ~~$54.0~~$54.2 million was available for use as of June 30, ~~2019.~~2020.

Note ~~15—~~13—Employee Benefit Plans

Defined Benefit ~~Plan~~Plans

The Company recognizes net periodic benefit cost based on the actuarial analysis performed at the previous year end, adjusted if certain significant events occur during the year.

The components of net periodic benefit cost follows:


		Three Months Ended June 30,						Six Months Ended June 30,							Three Months Ended June 30,				Six Months Ended June 30,
(in millions)	(in millions)	2019		2018		2019		2018		(in millions)	2020		2019		2020		2019
Service cost	Service cost	$	0.7	$	0.8	$	1.4	$	1.6	Service cost	$	0.8	$	0.7	$	1.5	$	1.4
Interest cost	Interest cost	1.5		1.4		3.0		2.8		Interest cost	1.2		1.5		2.3		3.0
Expected return on plan assets	Expected return on plan assets	(2.4)		(2.6)		(4.8)		(5.2)		Expected return on plan assets	(2.5)		(2.4)		(4.9)		(4.8)
Amortization of unrecognized loss¹		0.8		1.2		1.7		2.3
Amortization of unrecognized loss⁽¹⁾										Amortization of unrecognized loss⁽¹⁾	1.3		0.8		2.7		1.7
Net periodic benefit cost	Net periodic benefit cost	$	0.6	$	0.8	$	1.3	$	1.5	Net periodic benefit cost	$	0.8	$	0.6	$	1.6	$	1.3

^1.(1)Includes amortization of unrecognized actuarial (gain) loss and prior service credits and excludes provision for income tax of $(0.3) million and $(0.6) million for the three and six months ended June 30, 2020, respectively, and $(0.2) millionand $(0.4) million for the three and six months ended June 30, 2019, ~~respectively, and $(0.3) million for the six months ended June 30, 2018.~~respectively.

The components of net periodic benefit cost, other than the service cost component, are included in other non-operating ~~(income) expense,~~income, net.

Defined Contribution Plans

Deferred Compensation - Cash

The Company has established a Rabbi Trust to provide for a degree of financial security to cover its obligations with its deferred compensation plan. Contributions to the Rabbi Trust by the Company are made at the discretion of management and generally are made in cash and invested in money-market funds. The Company consolidates the Rabbi Trust and therefore includes the investments in its Condensed Consolidated Balance Sheets. As of June 30, 2020 and December 31, 2019, the Company had $7.0 million and $6.1 million of cash, respectively, and $5.6 million and $5.5 million of short-term investments, respectively. The short-term investments are measured at fair value using quoted market prices in active markets (i.e., Level 1 measurements) with changes in fair value recorded in net income and the associated cash flows presented as operating cash flows.

Note ~~16—~~14—Standard Product Warranties

The Company offers various standard warranty programs on its products, primarily for certain installed roofing systems, high-performance cables and assemblies, fluid technologies and braking products. The Company’s liability for such warranty programs is included in accrued ~~expenses.~~and other current liabilities. The change in standard product warranty liabilities for the six months ended June 30, follows:


(in millions)	(in millions)	2019		2018		(in millions)	2020		2019
Balance as of January 1	Balance as of January 1	$	31.9	$	30.4	Balance as of January 1	$	29.2	$	31.9
Current year provision		9.8		9.1
Provision						Provision	7.3		9.8

Current year claims		(10.4)		(7.8)
Claims						Claims	(6.6)		(10.4)

Currency translation		—		(0.2)

Balance as of June 30	Balance as of June 30	$	31.3	$	31.5	Balance as of June 30	$	29.9	$	31.3

Note ~~17—~~15—Financial Instruments

Foreign Currency Forward Contracts

The Company uses foreign currency forward contracts to hedge a portion of its foreign currency exchange rate exposure to forecasted foreign currency denominated cash flows. These instruments are not held for speculative or trading purposes.

A summary of the Company's designated and non-designated cash flow hedges follows:


		June 30, 2019						December 31, 2018							June 30, 2020				December 31, 2019
(in millions)	(in millions)	Fair Value¹		Notional Value		Fair Value¹		Notional Value		(in millions)	Fair Value⁽¹⁾		Notional Value		Fair Value⁽¹⁾		Notional Value
Designated hedges	Designated hedges	$	—	$	49.2	$	0.2	$	95.0	Designated hedges	$	0.2	$	92.0	$	2.0	$	108.1
Non-designated hedges	Non-designated hedges	0.4		50.0		0.1		49.9		Non-designated hedges	(0.2)		33.3		0.6		124.4

^1.(1)The fair value of foreign currency forward contracts is included in other current assets. The fair value was estimated using observable market inputs such as forward and spot prices of the underlying exchange rate pair. Based on these inputs, derivative assets and liabilities are classified as Level 2 in the fair value hierarchy.

Designated Hedges

For instruments that are designated and qualify as cash flow hedges, the Company had foreign currency forward contracts with maturities less than one year. The changes in the fair value of the contracts are recorded in accumulated other comprehensive income (loss) and recognized in the same line item as the impact of the hedged item, revenues or cost of sales, when the underlying forecasted transaction impacts earnings. The change in accumulated other comprehensive income (loss) related to foreign currency cash flow hedges was immaterial for the three and six months ended June 30, 2020 and 2019. Gains and losses on the contracts representing hedge components excluded from the assessment of ~~hedged~~hedge effectiveness are recognized in the same line item as the hedged item, revenues or cost of sales, currently.

~~The change in accumulated other comprehensive income (loss) related to cash flow hedges for the three and six months ended June 30, follows:~~

(in millions) 2019 2018
Balance as of April 1 $ (1.6) $ (3.8)
Other comprehensive loss before reclassifications (1.6) —
Amounts reclassified from accumulated other comprehensive loss — 0.3
Other comprehensive (loss) income (1.6) 0.3
Balance as of June 30 $ (3.2) $ (3.5)
(in millions) 2019 2018
Balance as of January 1 $ (3.2) $ (4.0)
Other comprehensive income before reclassifications 0.3 0.3
Amounts reclassified from accumulated other comprehensive loss (0.3) 0.2
Other comprehensive income — 0.5
Balance as of June 30 $ (3.2) $ (3.5)
Non-Designated Hedges

For instruments that are not designated as a cash flow hedge, the Company had foreign exchange contracts with maturities less than one year. The unrealized gains and losses resulting from these contracts were immaterial and are recognized in other non-operating ~~(income) expense,~~income, net and partially offset corresponding foreign exchange gains and losses on these balances.

~~Deferred Compensation Rabbi Trust~~

The Company has established a Rabbi Trust to provide for a degree of financial security to cover its obligations associated with its deferred compensation plan. Contributions to the Rabbi Trust by the Company are made at the discretion of management and generally are made in cash and invested in money-market funds. The Company consolidates the Rabbi Trust and therefore includes the investments in its Condensed Consolidated Balance Sheets. As of June 30, 2019 and December 31, 2018, the Company had $5.9 million and $10.7 million of cash, respectively, and $5.4 million and $4.3 million of short-term investments, respectively. The short-term investments are measured at fair value using quoted market prices in active markets (i.e., Level 1 measurements) with changes in fair value recorded in net income and the associated cash flows presented as operating cash flows.

Other Financial Instruments

Other financial instruments include cash and cash equivalents, accounts receivable, net, accounts payable, accrued liabilities and other, and long-term debt. The carrying ~~value~~amount for cash and cash equivalents, accounts receivable, net, accounts payable and accrued liabilities and other approximates fair value because of their short-term nature and generally negligible credit losses (refer to Note 1412 for the fair value of long-term debt).

Note ~~18—~~16—Commitments and Contingencies

Litigation

Over the years, the Company has been named as a defendant, along with numerous other defendants, in lawsuits in various ~~state~~ courts in which plaintiffs have alleged injury due to exposure to asbestos-containing brakes, which

Carlisle manufactured in limited amounts between the late-1940s and the mid-1980s. In addition to compensatory awards, these lawsuits may also seek punitive damages. Generally, the Company has obtained dismissals or settlements of its asbestos-related lawsuits with no material effect on its financial condition, results of operations, or cash flows. The Company maintains insurance coverage that applies to the Company’s defense costs and payments of settlements or judgments in connection with asbestos-related lawsuits. At this time, the amount of reasonably possible asbestos claims, if any, is not material to the Company's financial position, results of operations, or operating cash flows, although these matters could result in the Company being subject to monetary damages, costs or expenses, and charges against earnings in particular periods.

The Company may occasionally be involved in various other legal actions, including environmental matters, arising in the normal course of business. In the opinion of management, the ultimate ~~outcome~~outcomes of such actions, either individually or in the aggregate, are not expected to have a material adverse effect on the consolidated financial position or annual operating cash flows of the Company.

~~Environmental Matters~~

~~The~~Note 17—Subsequent Events

On July 22, 2020, the Company isacquired Motion Tech Automation, LLC ("MTA") for approximately $33.3 million in cash, subject to ~~increasingly stringent environmental laws~~post-closing adjustments. MTA is an industry leader in product development services and ~~regulations, including those relating to air emissions, wastewater discharges, chemical~~high precision, non-contact sensors.The initial accounting for the business combination is incomplete as a result of the timing of the acquisition. The results of operations of MTA's product development services and hazardous waste management, and disposal. Some of these environmental laws hold owners or operators of land or businesses liable for their own and for previous owners’ or operators’ releases of hazardous or toxic substances or wastes. Other environmental laws and regulations requirevalue added manufacturing operations will be reported within the ~~obtainment of, and compliance with, environmental permits. To date, costs of complying with environmental, health, and safety requirements have not been material,~~CFT reporting segment and the ~~Company did not have any significant accruals related to potential future costs~~precision sensors operations will be reported within the CIT reporting segment beginning in the third quarter of environmental remediation as of June 30, 2019, nor are any asset retirement obligations recorded as of that date. However, the nature of the Company’s operations and its long history of industrial activities at certain of its current or former facilities, as well as those acquired, could potentially result in material environmental liabilities or asset retirement obligations.

While the Company must comply with existing and pending climate change legislation, regulation, international treaties or accords, current laws and regulations do not have a material impact on its business, capital expenditures or financial position. Future events, including those relating to climate change or greenhouse gas regulation, could require the Company to incur expenses related to the modification or curtailment of operations, installation of pollution control equipment, or investigation and cleanup of contaminated sites.2020.

2223

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Carlisle Companies Incorporated ("Carlisle", the "Company", "we", "us" or "our") is a diversified, global portfolio of niche brands and businesses that ~~manufacture~~manufactures highly engineered ~~products.~~products and solutions for its customers. Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior shareholder and stakeholder returns by combining ~~a unique~~an entrepreneurial management style ~~of decentralization, entrepreneurial spirit, active mergers~~under a center-led approach, and ~~acquisitions, and a~~ balanced ~~approach to~~ capital deployment, all with a culture of responsible stewardship and continuous improvement as embodied in the Carlisle Operating System ("COS"). Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of our financial statements with a narrative from the perspective of Company management. All references to "Notes" refer to our Notes to Condensed Consolidated Financial Statements in Item 1 to this quarterly report on Form 10-Q.

Executive Overview

Carlisle’s global team has persevered throughout a challenging second quarter. We ~~focus~~are prudently adjusting our business operating norms in response to intensified and necessary health and safety guidelines, and declines in demand. We intend to stay on ~~achieving profitable growth in our segments both organically, through new product development, product line extensions and entering new markets, as well as through acquisitions~~a course of ~~businesses that complement our existing technologies, products and market channels. Resources are allocated among~~responsible business activity to maintain a stable foundation for the ~~operating segments based on senior management’s assessment of their ability to obtain leadership positions and competitive advantages~~post-COVID-19 recovery we know will arrive. However in the ~~markets they serve.~~near-term, all companies, including Carlisle, must brace for adjustments to business structures, employment, and pay policies as the timing remains unclear of a return to acceptable levels of safety to allow increased personal and economic activity. While Carlisle is in a strong position to weather a prolonged economic downturn, we are making necessary adjustments to our cost structure where appropriate to maintain that strength. We ~~focus on obtaining profitable growth through the following strategic factors:~~

•~~Driving above-market organic growth;~~

•~~Utilizing COS consistently~~remain committed to ~~drive efficiencies~~emerging in a very strong financial position, and ~~operating leverage;~~

•~~Building scale with synergistic acquisitions;~~

•~~Continuing~~in a position to ~~invest in and develop exceptional talent; and~~

•~~Deploying capital into capital expenditures, share repurchases and dividends.~~leverage anticipated future growth.

~~We are pleased with Carlisle's~~During the second quarter ~~sales and diluted earnings per share results. These~~financial results, ~~demonstrate~~ our ~~continued progress towards our Vision 2025 goals of: $8 billion in revenues, 20% operating income, and 15% return on invested capital.~~

~~Second quarter results were driven by: strong execution, continued solid demand at both~~performance was led by a resilient Carlisle Construction Materials ("CCM"). While the quarter began with April's volumes down in excess of 30 percent, we saw strong recovery in shipments through May and June, and we continue to benefit from the overall resumption of construction activity in both the U.S. and Europe. At Carlisle Interconnect Technologies ("CIT"), ~~price discipline across all four segments,~~we, like many others, were taken aback by the record global decline in aerospace production and ~~efficiencies gained from COS. We continue~~the accompanying ripple effects through the supply chain. The reality is that this crisis has devastated many aerospace participants. Our ongoing actions to ~~see a healthy backdrop~~restructure and rightsize our manufacturing footprint over the past few years, combined with accelerated restructuring taken in 2020, have positioned us to maintain profitability even as demand ~~for both new construction and replacement products across~~in the building envelope within CCM, while robust commercial aircraft build rates continue at CIT. Combined with price/cost dynamics and efficiencies gained from prior year restructuring efforts, we leveraged these positives into solid incremental margins. Additionally,aerospace industry reset materially in the second quarter. CIT's medical technologies platform, on the other hand, grew revenue 15 percent organically year-over-year during the second quarter driven by increased demand for COVID-19 related patient monitoring equipment. Recently acquired Providien, LLC ("Providien") also continued to perform well. At Carlisle Fluid Technologies ('CFT"), results each month improved throughout the second quarter and we continue our steady progress on the initiatives laid out in Vision 2025. Unfortunately, volume declines of over 30 percent weighed heavily on operating income results. Despite this, we remain committed to this platform and continue to add product breadth by investing in new products, such as our market differentiated fluid handling system for spray foam that launched in the second quarter. The pandemic crisis extended the pressure Carlisle Brake & Friction ("CBF") ~~continued~~was already experiencing in the global off-highway vehicle markets, offsetting the significant actions taken the past few years in this business, including the Tulsa to ~~execute~~Medina plant consolidation and obtaining Federal Aviation Authority Parts Manufacturer Approvals for aircraft carbon brakes. Given the actions taken over the past several years, its strong market position, and traction on new technology introductions, we expect CBF to leverage any improvements in volume well and await recovery from the pandemic.

As always, we remain very focused on ~~its margin expansion goals driven~~maintaining our financial and strategic flexibility to be able to best leverage future opportunities. During the first six months of 2020, we demonstrated this strength by ~~increased efficiencies at its Medina, Ohio facility.~~

~~During~~paying our dividend of $56.0 million, deploying $48.5 million into capital expenditures and investing $28.5 million into research and development. As of the end of the second quarter, ~~global macro uncertainties, including unresolved trade negotiations, Brexit,~~we have a ~~general slowing~~strong cash position of industrial capital spending, and severe weather in North America challenged the global Carlisle team. Despite these challenges, the team continued to drive sales and operating income improvements under Vision 2025 initiatives.

~~We also continued to work an active merger and acquisition pipeline, broadening~~$737.7 million with $1.0 billion undrawn on our scope and scale of product offerings as demonstrated by our second quarter acquisition of MicroConnex Corporation ("MicroConnex"), which adds key sensor and micro-flex circuit technology within CIT's medical technologies platform, and the acquisitions of Hosco Holdings, LLC, Integrated Dispense Solutions, LLC and Shinhang Systems Co., Ltd., to establish a sealants and adhesives platform within Carlisle Fluid Technologies ("CFT"revolving credit facility (the "Facility").

We enter the second half of 2020 cautiously optimistic and with confidence in our ability to deliver longer-term on Vision 2025. Needless to say, the COVID-19 pandemic continues to negatively impact our operations. The uncertainties remaining around the pandemic, including the length and severity of the economic downturn and continued tension with China, likely will result in a choppy path to ultimate recovery, and we are unable to predict the full extent or duration of these events on Carlisle at this time. However, given our strong balance sheet and cash flow generating capabilities, we are well prepared to navigate the future while maintaining our disciplined and opportunistic capital deployment strategy.

2324

Summary of Financial Results


		Three Months Ended June 30,									Six Months Ended June 30,										Three Months Ended June 30,						Six Months Ended June 30,
(in millions, except per share amounts)	(in millions, except per share amounts)	2019			2018			2019			2018			(in millions, except per share amounts)	2020			2019			2020			2019
Revenues	Revenues	$	1,314.8		$	1,236.1		$	2,386.7		$	2,220.8		Revenues	$	1,024.2		$	1,314.8		$	2,054.4		$	2,386.7

Operating income	Operating income	$	207.2		$	159.7		$	321.9		$	254.4		Operating income	$	113.4		$	207.2		$	216.1		$	321.9
Operating margin percentage	Operating margin percentage	15.8		%	12.9		%	13.5		%	11.5		%	Operating margin percentage	11.1		%	15.8		%	10.5		%	13.5		%
Income from continuing operations	Income from continuing operations	$	153.0		$	114.7		$	230.4		$	172.6		Income from continuing operations	$	75.4		$	153.0		$	137.2		$	230.4
(Loss) income from discontinued operations	(Loss) income from discontinued operations	$	(0.1)		$	(1.0)		$	1.9		$	250.7		(Loss) income from discontinued operations	$	—		$	(0.1)		$	—		$	1.9
Diluted earnings per share attributable to common shares:	Diluted earnings per share attributable to common shares:													Diluted earnings per share attributable to common shares:
Income from continuing operations	Income from continuing operations	$	2.65		$	1.87		$	3.98		$	2.78		Income from continuing operations	$	1.36		$	2.65		$	2.45		$	3.98
(Loss) income from discontinued operations		$	—		$	(0.02)		$	0.03		$	4.04
Income from discontinued operations														Income from discontinued operations	$	—		$	—		$	—		$	0.03

Items affecting comparability:¹
Items affecting comparability:⁽¹⁾														Items affecting comparability:⁽¹⁾
Impact to operating income	Impact to operating income	$	4.5		$	7.7		$	11.7		$	12.1		Impact to operating income	$	17.4		$	4.5		$	27.6		$	11.7
Impact to income from continuing operations	Impact to income from continuing operations	$	(1.9)		$	1.1		$	2.9		$	5.6		Impact to income from continuing operations	$	13.7		$	(1.9)		$	25.1		$	2.9
Impact on diluted EPS from continuing operations	Impact on diluted EPS from continuing operations	$	(0.03)		$	0.03		$	0.05		$	0.09		Impact on diluted EPS from continuing operations	$	0.25		$	(0.03)		$	0.45		$	0.05

^1.(1)Items affecting comparability primarily include acquisition related costs, exit and disposal costs, facility rationalization costs, litigation settlement costs, gains from divestitures, idle capacity and labor costs, net of subsidies, losses on debt extinguishment and discrete tax items. Tax effect is based on the rate of the jurisdiction where the expense is deductible. Refer to Items Affecting Comparability in this MD&A for further ~~discussion.~~information.

Revenues ~~increased~~decreased in the ~~second quarter and first six months of 2019~~2020 periods primarily reflecting ~~increased volume, company-wide price realization and contributions~~lower volumes in all of our segments, which were impacted by the global economic slowdown due to COVID-19. Contributions from ~~the~~ acquisitions, ~~of Petersen Aluminum Corporation ("Petersen") and MicroConnex,~~primarily Providien, partially offset ~~by foreign currency headwinds.~~the decrease in volume.

The ~~increase~~decrease in operating income in the ~~second quarter and first six months of 2019~~2020 periods primarily reflected ~~the above revenue performance~~lower volumes as well as lower production levels increasing per unit costs and ~~benefits from favorable raw material dynamics and the continued execution of COS,~~wage inflation. The decrease in operating income was partially offset by ~~higher labor-related costs.~~raw material savings, particularly in our CCM segment, lower incentive compensation and travel costs, and savings from COS.

Diluted earnings per share from continuing operations decreased primarily ~~benefited~~ from the above operating income performance ($~~0.59~~1.24 per share in the second quarter of 2020 and ~~$0.86 for~~$1.40 per share in the first six months of ~~2019),~~2020) and a higher effective tax rate in the second quarter of 2020 ($0.07 per share). The decrease was partially offset by reduced average shares outstanding ($~~0.15~~0.06 per share in the second quarter of 2020 and ~~$0.25 for the first six months of 2019) resulting from our share repurchase program, and a lower effective tax rate ($0.04~~$0.08 per share ~~in the second quarter and $0.07 for the first six months of 2019).~~

~~Outlook~~

We remain committed to a balanced capital deployment strategy: investing in organic growth, closing on several acquisitions, and returning capital to shareholders during the first six months, paying $232.1 million in share repurchases and $46.2 million in dividends.

~~Consolidated Results of Operations~~

~~Revenues~~

(in millions) Three Months Ended June 30, Acquisition Effect Price / Volume Effect Exchange Rate Effect
2019 2018 Change %
Revenues $ 1,314.8 $ 1,236.1 $ 78.7 6.4 % 4.7 % 2.3 % (0.6) %

The increase in revenues in the second quarter of 2019 primarily reflected increased sales volumes from favorable commercial construction demand at CCM and an increase in demand for aerospace products at CIT. Revenues also increased from company-wide price realization, particularly in the CCM segment. Revenues from acquired businesses in the second quarter of 2019 primarily reflected a contribution of $48.3 million from the acquisition of Petersen in the CCM segment and $3.0 million from the acquisition of MicroConnex in the CIT segment. The

~~increase in revenues was partially offset by lower sales volumes at CFT and CBF and unfavorable foreign currency rates due to a stronger U.S dollar.~~

(in millions) Six Months Ended June 30, Acquisition Effect Price / Volume Effect Exchange Rate Effect
2019 2018 Change %
Revenues $ 2,386.7 $ 2,220.8 $ 165.9 7.5 % 4.4 % 3.9 % (0.8) %

~~The increase in revenues~~ in the first six months of ~~2019 primarily reflected increased sale volumes~~2020) resulting from ~~favorable commercial construction demand at CCM and an increase~~our share repurchase program.

We generated $226.3 million in ~~demand for aerospace products at CIT. Revenues also increased from company-wide price realization, particularly in the CCM segment. Revenues from acquired businesses~~operating cash flow in the first six months of ~~2019~~2020, and utilized cash on hand and cash provided by operations to return capital to shareholders through dividends and share repurchases, and fund capital expenditures.

Consolidated Results of Operations

Revenues



(in millions)	2020		2019		Change		%		Acquisition Effect		Price / Volume Effect		Exchange Rate Effect
Three months ended June 30	$	1,024.2	$	1,314.8	$	(290.6)	(22.1)	%	1.9	%	(23.8)	%	(0.2)	%
Six months ended June 30	$	2,054.4	$	2,386.7	$	(332.3)	(13.9)	%	2.6	%	(16.2)	%	(0.3)	%

The decrease in revenues in the 2020 periods primarily reflected alower sales volumes in all segments, which were impacted by the global economic slowdown due to COVID-19. CIT volume decline was led by lower sales in the commercial aerospace market, partially offset by an increase in sales in the medical market, and CCM, CBF and CFT experienced declines in sales volumes across all markets in which they operate. Partially offsetting the decline was contribution of ~~$83.8~~$21.2 million in the second quarter and $45.1 million in the first six months of 2020 from the acquisition of ~~Petersen in the CCM segment and $3.0 million from the acquisition of MicroConnex~~Providien in the CIT segment. ~~The increase in revenues was partially offset by lower sales volumes at CBF and CFT and unfavorable foreign currency rates due to a stronger U.S dollar.~~

Gross Margin


(in millions)	(in millions)	Three Months Ended June 30,																									Six Months Ended June 30,																		(in millions)		Three Months Ended June 30,					Six Months Ended June 30,
					2019				2018			Change			%				2019				2018			Change			%	(in millions)				2020			2019		Change		%			2020			2019		Change		%
Gross margin	Gross margin	$	394.2			$	332.2			$	62.0		18.7	%		$	682.8			$	581.6			$	101.2		17.4	%	Gross margin		$	281.2		$	394.2		$	(113.0)	(28.7)	%	$	559.6		$	682.8		$	(123.2)	(18.0)	%
Gross margin percentage	Gross margin percentage	30.0		%		26.9		%								28.6		%		26.2		%							Gross margin percentage		27.5		%	30.0		%					27.2		%	28.6		%
Depreciation and amortization	Depreciation and amortization	$	24.5			$	24.1									$	47.1			$	50.3								Depreciation and amortization		$	29.9		$	24.5						$	61.4		$	47.1

~~The increase in gross~~Gross margin percentage (gross margin expressed as a percentage of revenues) declined in the ~~second quarter and first six months of 2019 was~~2020 periods, driven by ~~company-wide price realization, particularly~~lower sales volume in ~~the CCM segment,~~all segments, as well as lower production levels increasing per unit costs and wage inflation, partially offset by favorable raw material ~~dynamics,~~pricing and purchase savings from ~~COS and higher sales volumes in the CCM and CIT segments. Partially offsetting these items were higher labor-related costs.~~COS. Also included in cost of goods sold were exit and disposal costs totaling ~~$0.9~~$3.1 million infor the second quarter and $6.1 million for the first six months of ~~2019~~2020, primarily at CBF and CIT, attributable to our restructuring initiatives, compared with $0.9 million for the second quarter and $4.5 million for the first six months of ~~2019, compared with $3.7 million in the second quarter of 2018~~2019. Refer to Note 8 for further information on exit and ~~$6.0 million for the first six months of 2018, primarily at CIT, attributable to our restructuring initiatives.~~disposal activities.

Selling and Administrative Expenses


(in millions)	(in millions)	Three Months Ended June 30,																									Six Months Ended June 30,																		(in millions)		Three Months Ended June 30,					Six Months Ended June 30,
					2019				2018			Change			%				2019				2018			Change			%	(in millions)				2020			2019		Change		%			2020			2019		Change		%
Selling and administrative expenses	Selling and administrative expenses	$	172.3			$	159.9			$	12.4		7.8	%		$	336.5			$	308.5			$	28.0		9.1	%	Selling and administrative expenses		$	153.1		$	172.3		$	(19.2)	(11.1)	%	$	315.0		$	336.5		$	(21.5)	(6.4)	%
As a percentage of revenues	As a percentage of revenues	13.1		%		12.9		%								14.1		%		13.9		%							As a percentage of revenues		14.9		%	13.1		%					15.3		%	14.1		%
Depreciation and amortization	Depreciation and amortization	$	26.1			$	21.9									$	52.0			$	41.2								Depreciation and amortization		$	25.4		$	26.1						$	50.1		$	52.0

The ~~increase~~decrease in selling and administrative expenses in the ~~second quarter and first six months of 2019~~2020 periods primarily reflected ~~acquired selling general and administrative costs from the acquisitions of Petersen and MicroConnex, higher labor-related costs for equity and~~lower incentive compensation and ~~charges for the facility rationalization~~travel costs, and ~~plant restructuring projects at CIT and CFT.~~lower medical costs. The selling and administrative costs from the acquired businesses also included non-cash amortization of acquired customer-related intangible assets. Refer to Note 9 for further information on exit and disposal activities. These increasesdecreases were partially offset by ~~continuing cost savings from~~wage inflation and higher legal and termination costs associated with the ~~integration~~expiration of ~~acquired businesses.~~the agreement to acquire Draka Fileca SAS.

Research and Development Expenses


(in millions)	(in millions)	Three Months Ended June 30,																									Six Months Ended June 30,																		(in millions)		Three Months Ended June 30,					Six Months Ended June 30,
					2019				2018			Change			%				2019				2018			Change			%	(in millions)				2020			2019		Change		%			2020			2019		Change		%
Research and development expenses	Research and development expenses	$	15.4			$	14.2			$	1.2		8.5	%		$	29.8			$	28.1			$	1.7		6.0	%	Research and development expenses		$	14.1		$	15.4		$	(1.3)	(8.4)	%	$	28.5		$	29.8		$	(1.3)	(4.4)	%
As a percentage of revenues	As a percentage of revenues	1.2		%		1.1		%								1.2		%		1.3		%							As a percentage of revenues		1.4		%	1.2		%					1.4		%	1.2		%
Depreciation and amortization	Depreciation and amortization	$	0.5			$	0.3									$	1.0			$	0.7								Depreciation and amortization		$	0.7		$	0.5						$	1.3		$	1.0

Research and development expenses ~~remained consistent~~were lower in the 2020 periods, compared with the 2019 periods, primarily reflecting lower new product development costs at our CIT and CFT segments, partially offset by an increase in the CCM segment.

Other Operating Expense (Income), net


(in millions)	Three Months Ended June 30,																					Six Months Ended June 30,
			2020			2019			Change			%			2020			2019			Change			%
Other operating expense (income), net	$	0.6		$	(0.7)		$	(1.3)		185.7	%		$	—		$	(5.4)		$	5.4		(100.0)	%

Other operating expense (income), net in the second quarter of 2020 primarily reflected $2.1 million of losses on sale of assets, primarily at CBF and CIT, partially offset by $0.7 million of rebates and $0.3 million of royalty income. Other operating expense (income), net in the first six months of ~~2019, compared with the second quarter and first six months of 2018, and~~2020 primarily reflected ~~new product development~~$2.8 million of losses on sale of assets, primarily at ~~our CIT,~~CBF, CCM and ~~CFT segments.~~

~~Other Operating (Income) Expense, net~~

(in millions) Three Months Ended June 30, Six Months Ended June 30,
2019 2018 Change % 2019 2018 Change %
Other operating (income) expense, net $ (0.7) $ (1.6) $ 0.9 56.3 % $ (5.4) $ (9.4) $ 4.0 42.6 %
CIT, offset by $1.2 million of rebates and $0.7 million of royalty income.

Other operating expense (income) ~~expense,~~, net in the first six months of 2019 primarily reflected a $3.0 million gain on contingent consideration at CFT, $0.8 million of rebates and $0.6 million of gains on sales of assets, primarily at CBF.

Other operating (income) expense, net in the second quarter of 2018 primarily reflected $2.0 million of gains on sales of assets primarily at CIT and CFT, and in the first six months of 2018, primarily reflected the $4.9 million gain on a legal settlement at CCM and $4.0 million of gains on sales of assets primarily at CCM, CIT and CFT.

Operating Income


(in millions)	(in millions)	Three Months Ended June 30,																									Six Months Ended June 30,																		(in millions)		Three Months Ended June 30,					Six Months Ended June 30,
					2019				2018			Change			%				2019				2018			Change			%	(in millions)				2020			2019		Change		%			2020			2019		Change		%
Operating income	Operating income	$	207.2			$	159.7			$	47.5		29.7	%		$	321.9			$	254.4			$	67.5		26.5	%	Operating income		$	113.4		$	207.2		$	(93.8)	(45.3)	%	$	216.1		$	321.9		$	(105.8)	(32.9)	%
Operating margin percentage	Operating margin percentage	15.8		%		12.9		%								13.5		%		11.5		%							Operating margin percentage		11.1		%	15.8		%					10.5		%	13.5		%

Refer to Segment Results of Operations within this MD&A for further information related to segment operating income results.

Interest Expense, net


(in millions)	(in millions)	Three Months Ended June 30,																					Six Months Ended June 30,															(in millions)	Three Months Ended June 30,					Six Months Ended June 30,
				2019			2018			Change			%			2019			2018			Change			%	(in millions)			2020		2019		Change		%		2020		2019		Change		%
Interest expense		$	16.6		$	17.5								$	32.9		$	32.9
Interest income		(1.9)			(3.3)									(4.5)			(4.2)
Interest expense, net	Interest expense, net	$	14.7		$	14.2		$	0.5		3.5	%		$	28.4		$	28.7		$	(0.3)		(1.0)	%	Interest expense, net		$	19.8	$	16.6	$	3.2	19.3	%	$	38.7	$	32.9	$	5.8	17.6	%

~~The change in interest~~Interest expense, net during the 2020 periods primarily reflected higher long-term debt balances associated with our public offering of $750.0 million notes completed in February 2020, and draws on our revolving credit facility in the first quarter of 2020, which were repaid in the second quarter of 2020. Refer to Note 12 for further information on our long-term debt.

Loss on Extinguishment of Debt

Loss on extinguishment of debt related to the early redemption in full of our $250.0 million aggregate principal amount of our outstanding 5.125% notes due December 15, 2020 (the “2020 Notes”). The 2020 Notes were redeemed on March 29, 2020 at the redemption price of $262.1 million. The redemption price included a premium of $8.4 million, along with $0.4 million of deferred issuance costs and resulted in a loss of $8.8 million. Refer to Note 12 for further discussion.

Interest Income


(in millions)	Three Months Ended June 30,																					Six Months Ended June 30,
			2020			2019			Change			%			2020			2019			Change			%
Interest income	$	(2.7)		$	(1.9)		$	(0.8)		42.1	%		$	(3.4)		$	(4.5)		$	1.1		(24.4)	%

Interest income increased during the second quarter of 2020 primarily related to a higher cash balance. Interest income decreased during the first six months of ~~2019~~2020 primarily ~~reflected changes in interest income that varies based on our cash balance and mix of excess cash in high yield investments.~~related to lower yields.

Other Non-operating ~~(Income) Expense,~~Income, net


(in millions)	(in millions)	Three Months Ended June 30,																					Six Months Ended June 30,														(in millions)	Three Months Ended June 30,					Six Months Ended June 30,
				2019			2018			Change			%			2019			2018			Change		%	(in millions)			2020		2019		Change		%		2020		2019		Change		%
Other non-operating (income) expense		$	(0.6)		$	(0.7)		$	0.1		(14.3)	%		$	(1.0)		$	1.2		$	(2.2)		NM
Other non-operating income, net																								Other non-operating income, net		$	(0.7)	$	(0.6)	$	(0.1)	16.7	%	$	(1.2)	$	(1.0)	$	(0.2)	20.0	%

~~The change~~Other non-operating income, net, in ~~other~~the first six months of 2020 primarily reflected foreign exchange gains from the strengthening of the U.S. Dollar, partially offset by the release of a portion of the indemnification asset related to the Petersen acquisition resulting from escrow expirations.

Other non-operating ~~(income) expense,~~income, net, in the first six months of 2019 primarily reflected changes in foreign currencies against the U.S. Dollar.

Income Taxes


(in millions)	(in millions)	Three Months Ended June 30,																									Six Months Ended June 30,																		(in millions)		Three Months Ended June 30,					Six Months Ended June 30,
					2019				2018			Change			%				2019				2018			Change			%	(in millions)				2020			2019		Change		%			2020			2019		Change		%
Provision for income taxes	Provision for income taxes	$	40.1			$	31.5			$	8.6		27.3	%		$	64.1			$	51.9			$	12.2		23.5	%	Provision for income taxes		$	21.6		$	40.1		$	(18.5)	(46.1)	%	$	36.0		$	64.1		$	(28.1)	(43.8)	%
Effective tax rate	Effective tax rate	20.8		%		21.5		%								21.8		%		23.1		%							Effective tax rate		22.3		%	20.8		%					20.8		%	21.8		%

The effective income tax rate on continuing operations for the first six months of 2020 was 20.8%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 24.0% and a year-to-date net discrete tax benefit of $5.3 million. The year-to-date net discrete tax benefit relates primarily to a reduction of unrecognized income tax benefits of $5.5 million.

The effective income tax rate on continuing operations for the first six months of 2019 was 21.8%. ~~The year-to-date provision for income taxes included taxes on earnings at an anticipated rate~~

Income from Discontinued Operations

Income from discontinued operations of 23.7% and a year-to-date net discrete tax benefit of $5.0 million. The year-to-date net discrete tax benefit relates primarily to a reduced tax liability on prior year tax filings finalized in the current quarter of $2.7$1.9 million ~~excess tax benefits related to employee stock compensation of $1.5 million, and a reduction of unrecognized income tax benefits of $1.2 million.~~

~~The effective income tax rate on continuing operations~~ for the first six months of 2018, was 23.1%. The year-to-date provision for income taxes included taxes on earnings at an anticipated full-year rate of approximately 24.7%, and a year-to-date net discrete tax expense of $3.5 million.

~~Income from Discontinued Operations~~

(in millions) Three Months Ended June 30, Six Months Ended June 30,
2019 2018 Change % 2019 2018 Change %
(Loss) income from discontinued operations before taxes $ — $ (1.3) $ — $ 297.7
Provision (benefit) for income taxes 0.1 (0.3) (1.9) 47.0
(Loss) income from discontinued operations $ (0.1) $ (1.0) $ 0.9 NM $ 1.9 $ 250.7 $ (248.8) NM

~~Income from discontinued operations in~~ 2019 relates solely to the settlement of prior income tax ~~positions in the current year.~~

Income from discontinued operations in 2018 primarily reflects the pre-tax gain on sale of CFS totaling $293.5 million. Excluding the gain on sale, income from discontinued operations reflects activity from January 1, 2018 through March 20, 2018, the date that the sale of CFS was completed.positions.

Segment Results of Operations

We continue to operate our facilities as essential business operations, while adhering to all health and safety measures for onsite employees. We have taken several steps to address the overall effects of COVID-19 on Carlisle and continue to assess the risks and potential impacts on our businesses. We have developed plans and implemented actions to mitigate risks and enhance the performance of our businesses in an uncertain environment dependent largely on future developments, which are highly uncertain and cannot be predicted.

Carlisle Construction Materials ("CCM")

~~On January 11, 2019,~~CCM's manufacturing plants in Europe that had temporary suspensions of operations are now operating at nearly normal capacity. Demand for non-residential roofing solutions is predominantly replacement-driven, and we ~~acquired Petersen for consideration~~continue to benefit from the overall resumption of ~~$207.2 million, including $5.2 million~~related construction work in both the U.S. and Europe. CCM's operating margins of ~~cash acquired~~18.7% during the quarter are a testament to our excellent management team, suite of valued products and ~~post-closing adjustments, which were finalized~~delivery of the premium Carlisle Experience. The actions taken at CCM prior to and during COVID-19 have solidified its place as a go-to supplier of building envelope solutions. Notably, CCM's newer metal and polyurethane platforms performed very well in the ~~first quarter of 2019. Petersen’s primary business is the manufacture~~quarter. Lastly, we remain price disciplined and distribution of market leading architectural metal roof panels, steel and aluminum flat sheets and coils, wall panels, perimeter roof edge systems and related accessories for commercial, residential, institutional, industrial and agricultural markets. Refer to Note 4 for further discussion.expect a substantial raw material benefit year-over-year in 2020.


(in millions)	(in millions)	Three Months Ended June 30,																						Acquisition Effect				Price / Volume Effect				Exchange Rate Effect		(in millions)			Three Months Ended June 30,															Acquisition Effect	Price / Volume Effect	Exchange Rate Effect
					2019				2018			Change			%																					(in millions)					2020			2019			Change			%	Exchange Rate Effect
Revenues	Revenues	$	915.0			$	828.6			$	86.4		10.4	%		6.1	%	4.7	%	(0.4)	%		Revenues			$	734.9			$	915.0			$	(180.1)			(19.7)		%		0.1	%		(19.7)	%		(0.1)	%
Operating income	Operating income	$	182.5			$	141.4			$	41.1		29.1	%								Operating income			$	137.6			$	182.5			$	(44.9)			(24.6)		%
Operating margin percentage	Operating margin percentage	19.9		%		17.1		%														Operating margin percentage			18.7		%		19.9		%
Depreciation and amortization	Depreciation and amortization	$	23.2			$	19.5															Depreciation and amortization			$	25.0			$	23.2
Items affecting comparability¹		$	0.2			$	0.7
Items affecting comparability⁽¹⁾																						Items affecting comparability⁽¹⁾			$	1.3			$	0.2

^1.(1)Items affecting comparability include ~~acquisition related~~idle capacity and labor costs, ~~($0.2~~net of subsidies, of $1.1 million, and exit and disposal and facility rationalization costs of $0.2 million in the second quarter of ~~2019~~2020 and ~~$0.7~~exit and disposal and facility rationalization costs of $0.2 million in the second quarter of ~~2018),~~2019, refer to Items Affecting Comparability.

CCM’s revenue ~~growth~~decline in the second quarter of ~~2019~~2020 primarily reflected ~~revenue contribution from the acquisition of Petersen, higher~~lower sales volumes ~~driven by U.S. roofing~~across all of our product lines due to delays in customer demand ~~price realization,~~ and in new ~~product development.~~construction projects attributable to COVID-19.

CCM’s operating margin percentage ~~growth~~decline in the second quarter of ~~2019~~2020 primarily reflected ~~favorable raw material dynamics, price realization, higher sales~~lower volumes, ~~and cost savings from COS,~~ partially offset by ~~higher labor related~~raw material savings, particularly MDI, and lower travel and other administrative costs.


(in millions)	(in millions)	Six Months Ended June 30,																						Acquisition Effect				Price / Volume Effect				Exchange Rate Effect		(in millions)			Six Months Ended June 30,															Acquisition Effect	Price / Volume Effect	Exchange Rate Effect
					2019				2018			Change			%																					(in millions)					2020			2019			Change			%	Exchange Rate Effect
Revenues	Revenues	$	1,586.1			$	1,427.2			$	158.9		11.1	%		6.2	%	5.3	%	(0.4)	%		Revenues			$	1,411.3			$	1,586.1			$	(174.8)			(11.0)		%		0.2	%		(11.0)	%		(0.2)	%
Operating income	Operating income	$	275.4			$	217.2			$	58.2		26.8	%								Operating income			$	245.3			$	275.4			$	(30.1)			(10.9)		%
Operating margin percentage	Operating margin percentage	17.4		%		15.2		%														Operating margin percentage			17.4		%		17.4		%
Depreciation and amortization	Depreciation and amortization	$	45.8			$	38.6															Depreciation and amortization			$	49.8			$	45.8
Items affecting comparability¹		$	1.8			$	(1.1)
Items affecting comparability⁽¹⁾																						Items affecting comparability⁽¹⁾			$	1.9			$	1.8

^1.(1)Items affecting comparability include idle capacity and labor costs, net of subsidies, of $2.2 million, acquisition related costs of $0.2 million, exit and disposal and facility rationalization costs of $0.3 million and $(0.8) million from the sale of a business during the first six months of 2020, and acquisition related costs of $1.6 million and exit and disposal and facility rationalization costs of $0.2 million in the first six months of 2019, ~~and acquisition related costs of $0.7 million and gains from divestitures of $(1.8) million in the first six months of 2018,~~ refer to Items Affecting Comparability.

CCM’s revenue ~~growth~~decline in the first six months of ~~2019~~2020 primarily reflected ~~revenue contribution from the acquisition of Petersen, higher~~lower sales volumes ~~driven by U.S. roofing~~across all of our product lines due to delays in customer demand ~~growth~~and in ~~Europe, price realization, and~~ new ~~product development.~~

construction projects attributable to from COVID-19.

CCM’s operating margin percentage ~~increase~~was flat in the first six months of ~~2019 was~~2020, driven by ~~price realization, favorable~~ raw material ~~dynamics, higher sales volumes~~savings, lower travel and ~~cost~~administrative costs and savings from ~~COS. Partially offsetting the increase in operating margin percentage were higher labor-related costs.~~COS, offset by lower volumes.

~~Outlook~~

CCM’s revenues and operating income are generally higher in the second and third quarters of the year due to increased construction activity during these periods, however could be impacted by unfavorable weather. CCM’s commercial roofing business is comprised predominantly of revenues from re-roofing, which derives demand from a large base of installed roofs requiring replacement in a given year, and less from roofing for new commercial construction. Demand for commercial insulation products is also driven by increased enforcement of building codes related to energy efficiency. Growth in demand in the commercial construction market can be negatively impacted by changes in fiscal policy and increases in interest rates. The availability of labor to fulfill installations may also be a constraint on growth in the commercial roofing market.

CCM’s ability to increase current selling price and volume levels is subject to significant competition, in particular from competitors that have added manufacturing capacity of commercial roofing and insulation, spray foam polyurethane products and metal roofing. Raw material input costs are expected to continue to increase moderately due to crude oil and related commodity pricing. Despite recent price realization, price competition could negatively impact CCM's ability to maintain current operating income margin levels or obtain incremental operating margin.

~~We continue to expect CCM to achieve low-double digit revenue growth in 2019.~~

Carlisle Interconnect Technologies ("CIT")

Operations at certain CIT manufacturing facilities in the U.S., Mexico and China that were temporarily suspended have resumed operations. CIT has responded well to the lower demand environment within global aerospace, which we anticipate will remain subdued for some time. Our accelerated restructuring plans put in place this spring remain generally on schedule, with the goals of achieving profitability levels contemplated in Vision 2025 fully intact. We do see some positive signs in the aerospace markets with passenger miles increasing and Boeing's 737 MAX moving closer to Federal Aviation Authority approval.

CIT's medical technologies platform grew 15 percent organically year-over-year during the second quarter driven by increased demand for patient monitoring equipment. Recently acquired Providien also continued to perform well. In addition, product rationalization actions taken by CIT medical in 2018 and 2019 have improved its margin profile, with continued COS efforts further enhancing profitability levels.

In April 2020, we announced plans to exit our manufacturing operations in Mobile, Alabama, and relocate the majority of those operations to CIT's existing manufacturing facility in Franklin, Wisconsin. This project is substantially complete with cumulative costs of $1.4 million recognized through June 30, 2020.

In January 2019, we announced ~~we would exit~~the relocation of our connectors manufacturing operations in El Segundo, California, and Riverside, California, ~~and relocate the majority of those operations~~ to our existing ~~manufacturing~~lower cost facilities in North America. This project is ~~expected to take 12 to 18 months to complete. Total project~~substantially complete with cumulative costs ~~are expected to be approximately $17.0~~of $20.7 million with approximately $7.5 million remaining to be incurred. As a result of these efforts, focused on improving operational efficiencies throughout the business, we anticipate continuing costs related to plant restructuring and facility rationalization throughout 2019.recognized through June 30, 2020. Refer to Note 98 for further information regarding exit and disposal activities.

On April 1, 2019, the Company acquired MicroConnex for approximately $46.8 million in cash. MicroConnex is a manufacturer of highly engineered microminature flex circuits and sensors for the medical and test and measurement markets. Refer to Note 4 for further discussion.


(in millions)	(in millions)	Three Months Ended June 30,																						Acquisition Effect				Price / Volume Effect				Exchange Rate Effect		(in millions)			Three Months Ended June 30,															Acquisition Effect	Price / Volume Effect	Exchange Rate Effect
					2019				2018			Change			%																					(in millions)					2020			2019			Change			%	Exchange Rate Effect
Revenues	Revenues	$	245.4			$	237.7			$	7.7		3.2	%		1.6	%	2.2	%	(0.6)	%		Revenues			$	184.0			$	245.4			$	(61.4)			(25.0)		%		8.6	%		(33.5)	%		(0.1)	%
Operating income		$	35.9			$	27.5			$	8.4		30.5	%
Operating (loss) income																						Operating (loss) income			$	(1.5)			$	35.9			$	(37.4)			(104.2)		%
Operating margin percentage	Operating margin percentage	14.6		%		11.6		%														Operating margin percentage			(0.8)		%		14.6		%
Depreciation and amortization	Depreciation and amortization	$	15.7			$	14.7															Depreciation and amortization			$	19.7			$	15.7
Items affecting comparability¹		$	2.4			$	1.9
Items affecting comparability⁽¹⁾																						Items affecting comparability⁽¹⁾			$	7.4			$	2.4

^1.(1)Items affecting comparability include idle capacity and labor costs, net of subsidies, of $2.4 million, exit and disposal and facility rationalization costs ($~~1.8~~5.0 million in the second quarter of ~~2019~~2020 and ~~$2.1~~$1.8 million in the second quarter of ~~2018). Items affecting comparability also include~~2019) and acquisition related costs of $0.6 million in the second quarter of 2019, ~~and legal settlements of $1.4 million and gains from divestitures of $(1.6) million in the second quarter of 2018,~~ refer to Items Affecting Comparability.

CIT's revenue ~~growth~~decline in the second quarter of ~~2019~~2020 primarily reflected ~~increases~~lower volumes, led by the commercial aerospace market as a result of continued delays in the ~~aerospace~~737 Max production and lower build rates on narrow and wide body aircraft by original equipment manufacturers ("OEMs") given steep declines in airline travel and customer plant shutdowns. The decline was partially offset by organic growth in the medical market and acquired product lines from Providien, that are sold into medical device end markets.

CIT’s operating margin percentage ~~increased~~decreased in the second quarter of ~~2019,~~2020, driven by lower volumes, higher restructuring costs and wage and raw material inflation, partially offset by savings from ~~COS, price realization and higher volumes, partially offset by higher labor-related costs.~~COS.


(in millions)	(in millions)	Six Months Ended June 30,																						Acquisition Effect				Price / Volume Effect				Exchange Rate Effect		(in millions)			Six Months Ended June 30,															Acquisition Effect	Price / Volume Effect	Exchange Rate Effect
					2019				2018			Change			%																					(in millions)					2020			2019			Change			%	Exchange Rate Effect
Revenues	Revenues	$	491.8			$	462.0			$	29.8		6.5	%		0.9	%	6.1	%	(0.5)	%		Revenues			$	408.5			$	491.8			$	(83.3)			(16.9)		%		9.8	%		(26.6)	%		(0.1)	%
Operating income	Operating income	$	66.5			$	54.7			$	11.8		21.6	%								Operating income			$	14.9			$	66.5			$	(51.6)			(77.6)		%
Operating margin percentage	Operating margin percentage	13.5		%		11.8		%														Operating margin percentage			3.6		%		13.5		%
Depreciation and amortization	Depreciation and amortization	$	30.2			$	29.3															Depreciation and amortization			$	38.8			$	30.2
Items affecting comparability¹		$	7.3			$	4.5
Items affecting comparability⁽¹⁾																						Items affecting comparability⁽¹⁾			$	12.7			$	7.3

^1.(1)Items affecting comparability include idle capacity and labor costs, net of subsidies, of $4.3 million, exit and disposal and facility rationalization costs ($~~6.5~~8.4 million in the first six months of ~~2019~~2020 and ~~$4.7~~$6.5 million in the first six months of ~~2018). Items affecting comparability also include~~2019) and acquisition related costs of $0.8 million in the first six months of 2019, ~~and legal settlements of $1.4 million and gains from divestitures of $(1.6) million in the first six months of 2018,~~ refer to Items Affecting Comparability.

CIT's revenue ~~growth~~decline in the first six months of ~~2019~~2020 primarily reflected ~~increases~~lower volumes, led by the commercial aerospace market as a result of continued delays in the ~~aerospace, industrial~~737 Max production and ~~defense~~lower build rates on narrow and wide body aircraft by OEMs given steep declines in airline travel and customer plant shutdowns. The decline was partially offset by organic growth in the medical market and acquired product lines from Providien, that are sold into medical device end markets.

CIT’s operating margin percentage ~~increased~~decreased in the first six months of ~~2019,~~2020, driven by ~~savings from COS, higher~~lower volumes, wage and ~~price realization, partially offset by higher labor-related costs, unfavorable product mix~~raw material inflation, and higher restructuring and facility rationalization ~~costs.~~

~~Outlook~~

The longer term outlook in the commercial aerospace market remains favorable with a strong delivery cycle for new commercial aircraft expected over the next several years. The outlook for the market for in-flight entertainment and connectivity applications also remains positive on increasing demand for on-board connectivity applications used in both installed aircraft seating and through personal mobile devices using wireless connectivity access.

CIT is actively pursuing new products, customers and complementary technologies to support its expansion into the growing medical technology market. The medical technology markets in which CIT competes are experiencing vendor consolidation trends among larger medical original equipment manufacturers to whom CIT offers improved product verification capabilities and value-added vertical integration through its multiple product offerings.

~~We continue to expect CIT to achieve mid-to-high single digit revenue growth in 2019.~~costs, partially offset by savings from COS.

Carlisle Fluid Technologies ("CFT")

(in millions) Three Months Ended June 30, Acquisition Effect Price / Volume Effect Exchange Rate Effect
2019 2018 Change %
Revenues $ 67.3 $ 73.3 $ (6.0) (8.2) % 5.9 % (11.7) % (2.4) %
Operating income $ 3.3 $ 7.8 $ (4.5) (57.7) %
Operating margin percentage 4.9 % 10.6 %
Depreciation and amortization $ 6.0 $ 6.0
Items affecting comparability¹
$ 1.3 $ 1.0

^1.~~Items affecting comparability include exit and disposal and facility rationalization costs ($0.1 million~~At CFT, each month improved throughout the quarter while we right-sized the business to fit the current demand environment. We see positive signs in the second quarter of 2019 and $1.3 million in the second quarter of 2018). Items affecting comparability also include acquisition related costs of $1.2 million in the second quarter of 2019, and a gain from divestiture of $(0.3) million in the second quarter of 2018, refer to ~~Items Affecting Comparability~~.

CFT's ~~revenue declined in the second quarter of 2019, reflecting lower sales volumes across all~~ end markets and ~~foreign currency headwinds, partially offset by acquisitions~~are cautiously optimistic for an improved second half of 2020 due to the work and ~~price realization.~~investments we have made to improve the business and early signs of stability in demand, particularly in Asia.

CFT’s operating margin percentage performance for the second quarter of 2019 declined, reflecting lower sales volumes, raw material and wage inflation, and acquisition-related costs, partially offset by price realization and savings from COS.


(in millions)	(in millions)	Six Months Ended June 30,																						Acquisition Effect				Price / Volume Effect				Exchange Rate Effect		(in millions)			Three Months Ended June 30,															Acquisition Effect	Price / Volume Effect	Exchange Rate Effect
					2019				2018			Change			%																					(in millions)					2020			2019			Change			%	Exchange Rate Effect
Revenues	Revenues	$	130.4			$	136.8			$	(6.4)		(4.7)	%		3.1	%	(5.2)	%	(2.6)	%		Revenues			$	46.5			$	67.3			$	(20.8)			(30.9)		%		4.3	%		(34.2)	%		(1.0)	%
Operating income		$	9.7			$	13.5			$	(3.8)		(28.1)	%
Operating (loss) income																						Operating (loss) income			$	(5.2)			$	3.3			$	(8.5)			(257.6)		%
Operating margin percentage	Operating margin percentage	7.4		%		9.9		%														Operating margin percentage			(11.2)		%		4.9		%
Depreciation and amortization	Depreciation and amortization	$	11.7			$	11.4															Depreciation and amortization			$	5.4			$	6.0
Items affecting comparability¹		$	0.4			$	1.5
Items affecting comparability⁽¹⁾																						Items affecting comparability⁽¹⁾			$	2.1			$	1.3

^1.(1)Items affecting comparability include exit and disposal and facility rationalization costs ($2.1 million in the ~~first six months~~second quarter of ~~2019~~2020 and ~~$2.0~~$0.1 million in the ~~first six months~~second quarter of ~~2018)~~2019) and acquisition related costs of $1.2 million in the second quarter of 2019, refer to Items Affecting Comparability.

CFT's revenue decrease in the second quarter of 2020 reflected volume declines due to COVID-19, particularly in the industrial and automotive end markets in all geographic regions, partially offset by contributions from acquisitions.

CFT’s operating margin percentage performance for the second quarter of 2020 declined, reflecting lower volumes, restructuring charges and wage and raw material inflation, partially offset by savings from COS.


(in millions)	Six Months Ended June 30,																				Acquisition Effect	Price / Volume Effect	Exchange Rate Effect
				2020				2019			Change			%
Revenues	$	104.8			$	130.4			$	(25.6)		(19.6)	%		8.1	%	(26.8)	%	(0.9)	%
Operating (loss) income	$	(2.4)			$	9.7			$	(12.1)		(124.7)	%
Operating margin percentage	(2.3)		%		7.4		%
Depreciation and amortization	$	11.6			$	11.7
Items affecting comparability⁽¹⁾	$	2.4			$	0.4

⁽¹⁾Items affecting comparability include exit and disposal and facility rationalization costs of $2.1 million, idle capacity and labor costs, net of subsidies, of $0.1 million and acquisition related costs of $0.2 million in the second quarter of 2020. Items affecting comparability also include exit and disposal and facility rationalization costs of $2.1 million, acquisition related costs of $1.3 million and a gain on contingent consideration of $(3.0) million in the ~~first six months~~second quarter of 2019, ~~and gain from divestiture of $(0.5) million in the first six months of 2018,~~ refer to Items Affecting Comparability.

CFT's revenue ~~declined~~decrease in the first six months of ~~2019, reflecting lower sales volumes across all~~2020 reflected volume declines due to COVID-19, particularly in the industrial and automotive end markets ~~and foreign currency headwinds,~~in all geographic regions, partially offset by ~~acquisitions and price realization.~~contributions from acquisitions.

CFT’s operating margin percentage performance for the first six months of ~~2019~~2020 declined, reflecting lower ~~sales~~ volumes and wage and raw material ~~and wage~~ inflation, ~~and acquisition-related costs,~~ partially offset by ~~a one-time gain on contingent consideration from a previous acquisition,~~ savings from ~~COS and price realization.~~

~~Outlook~~

~~The longer term outlook in the transportation and general industrial markets remains steady.~~ Difficult market conditions are expected to continue for the remainder of the year in the transportation and industrial markets, particularly in China, but the long-term outlook for these markets remains positive. We anticipate further revenue opportunity from the launch of new products, as well as the acceleration of key strategic growth areas: powder, sealants and adhesives and fast set.

~~We continue to expect CFT to achieve mid-single digit revenue growth in 2019.~~COS.

Carlisle Brake & Friction ("CBF")

(in millions) Three Months Ended June 30, Acquisition Effect Price / Volume Effect Exchange Rate Effect
2019 2018 Change %
Revenues $ 87.1 $ 96.5 $ (9.4) (9.7) % — % (7.0) % (2.7) %
Operating income $ 8.3 $ 2.9 $ 5.4 186.2 %
Operating margin percentage 9.5 % 3.0 %
Depreciation and amortization $ 5.5 $ 5.4
Items affecting comparability¹
$ 0.5 $ 3.9
CBF's manufacturing facilities in Europe that were temporarily idled have resumed operations. CBF remains focused on commercial and operational improvements, with the goal of remaining profitable even in a market trough environment. Given the actions taken over the past several years, its strong market position and traction on new technology introductions, CBF is positioned to leverage volume improvement.

During the first quarter of 2020, we initiated plans to consolidate certain operations globally to reduce costs and streamline processes by consolidating certain positions within selling, general and administrative, and manufacturing functions and exited less profitable product lines that resulted in asset write-offs. The project is estimated to take 9 to 12 months to complete. Total associated costs are expected to approximate $5.8 million, with approximately $1.6 million of costs remaining to be incurred, primarily in the second half of 2020.


(in millions)	Three Months Ended June 30,																				Acquisition Effect	Price / Volume Effect	Exchange Rate Effect
				2020				2019			Change			%
Revenues	$	58.8			$	87.1			$	(28.3)		(32.5)	%		—	%	(31.1)	%	(1.4)	%
Operating (loss) income	$	(1.6)			$	8.3			$	(9.9)		(119.3)	%
Operating margin percentage	(2.7)		%		9.5		%
Depreciation and amortization	$	5.0			$	5.5
Items affecting comparability⁽¹⁾	$	1.7			$	0.5

^1.(1)Items affecting comparability include idle capacity and labor costs, net of subsidies, of $0.3 million and include exit and disposal and facility rationalization costs ($~~0.5~~1.4 million in the second quarter of ~~2019~~2020 and ~~$3.9~~$0.5 million in the second quarter of ~~2018)~~2019), refer to Items Affecting Comparability.

~~CBF~~CBF's revenue ~~decreased~~decrease in the second quarter of ~~2019, reflecting weaker than expected sales volumes~~2020 reflected difficult year-over-year volume comparisons as a result of declines in demand due to plant closures from COVID-19 in the heavy equipment and transportation markets and foreign currency ~~headwinds, partially offset by price realization.~~headwinds.

CBF's operating margin percentage ~~increase~~decrease in the second quarter of ~~2019~~2020 was driven by lower volumes, wage inflation, and higher restructuring and facility rationalization costs, ~~associated with our Tulsa, Oklahoma to Medina, Ohio facility consolidation, savings from COS and price realization,~~ partially offset by ~~lower sales volumes, higher labor-related costs and raw material inflation.~~savings from COS.


(in millions)	(in millions)	Six Months Ended June 30,																						Acquisition Effect				Price / Volume Effect				Exchange Rate Effect		(in millions)			Six Months Ended June 30,															Acquisition Effect	Price / Volume Effect	Exchange Rate Effect
					2019				2018			Change			%																					(in millions)					2020			2019			Change			%	Exchange Rate Effect
Revenues	Revenues	$	178.4			$	194.8			$	(16.4)		(8.4)	%		—	%	(5.4)	%	(3.0)	%		Revenues			$	129.8			$	178.4			$	(48.6)			(27.2)		%		—	%		(25.8)	%		(1.4)	%
Operating income		$	14.8			$	7.4			$	7.4		100.0	%
Operating (loss) income																						Operating (loss) income			$	(5.4)			$	14.8			$	(20.2)			(136.5)		%
Operating margin percentage	Operating margin percentage	8.3		%		3.8		%														Operating margin percentage			(4.2)		%		8.3		%
Depreciation and amortization	Depreciation and amortization	$	10.9			$	11.5															Depreciation and amortization			$	10.9			$	10.9
Items affecting comparability¹		$	1.8			$	5.9
Items affecting comparability⁽¹⁾																						Items affecting comparability⁽¹⁾			$	5.4			$	1.8

^1.(1)Items affecting comparability include idle capacity and ~~include~~labor costs, net of subsidies, of $1.2 million and exit and disposal and facility rationalization costs ($~~1.8~~4.2 million in the first six months of ~~2019~~2020 and ~~$5.9~~$1.8 million in the first six months of ~~2018)~~2019), refer to Items Affecting Comparability.

~~CBF~~CBF's revenue ~~decreased~~decrease in the first six months of ~~2019, reflecting weaker than expected sales volumes~~2020 reflected difficult year-over-year volume comparisons as a result of declines in demand due to plant closures from COVID-19 in the heavy

equipment and transportation markets and foreign currency ~~headwinds, partially offset by price realization.~~headwinds.

CBF's operating margin percentage ~~increase~~decrease in the first six months of ~~2019~~2020 was driven by lower volumes, wage inflation, and higher restructuring and facility rationalization costs, ~~associated with our Tulsa, Oklahoma to Medina, Ohio facility consolidation, savings from COS and price realization,~~ partially offset by ~~lower sales volumes, unfavorable product mix, higher labor-related costs and raw material inflation.~~

~~Outlook~~

~~We now to expect CBF revenues to be down mid-single digits in 2019.~~savings from COS.

Liquidity and Capital Resources

A summary of our cash and cash equivalents by region follows:


(in millions)	(in millions)	June 30, 2019		December 31, 2018		(in millions)	June 30, 2020		December 31, 2019
Europe	Europe	$	92.3	$	39.3	Europe	$	176.6	$	62.2
North America (excluding U.S.)	North America (excluding U.S.)	23.1		28.6		North America (excluding U.S.)	32.9		43.4
China	China	40.2		28.6		China	31.1		17.9
Asia Pacific (excluding China)	Asia Pacific (excluding China)	44.6		19.5		Asia Pacific (excluding China)	35.2		69.1

International cash and cash equivalents	International cash and cash equivalents	200.2		116.0		International cash and cash equivalents	275.8		192.6
U.S. cash and cash equivalents	U.S. cash and cash equivalents	221.8		687.6		U.S. cash and cash equivalents	461.9		158.6
Total cash and cash equivalents	Total cash and cash equivalents	$	422.0	$	803.6	Total cash and cash equivalents	$	737.7	$	351.2

We maintain liquidity sources primarily consisting of cash and cash equivalents as well as availability under our ~~revolving credit facility (the "Facility"). Cash generated by operations~~Facility. In the near term, cash on hand is our primary source of liquidity. ~~Another potential source of liquidity is access to public capital markets via our automatic registration statement on Form S-3 filed November 8, 2017, subject to market conditions at that time.~~ The ~~decrease~~increase in cash and cash equivalents compared to December 31, ~~2018,~~2019, was primarily related to proceeds from our bond offering of $750.0 million notes due in March 2030, partially offset by the ~~acquisitions~~early redemption of ~~Petersen and MicroConnex, which were completed during the first six months of 2019.~~our $250.0 million notes due in December 2020. Additionally, during the first six months of ~~2019,~~2020, we utilized cash on hand to fund share repurchases, capital expenditures and pay dividends to shareholders.

Cash held ~~by subsidiaries~~ in China is subject to local laws and regulations that require government approval for conversion of such cash to U.S. Dollars, as well as for transfer of such cash ~~to entities that are~~ outside of China.

Despite the continued uncertainty in global markets resulting from COVID-19, we believe we have sufficient ~~financial resources~~cash on hand, availability under the Facility and operating cash flows to meet our business requirements for at least the next 12 ~~months,~~months. At the discretion of management, the Company may use available cash on non-operating purchases including capital expenditures for worldwide manufacturing, ~~working capital requirements,~~ dividends, common stock repurchases, acquisitions and strategic investments.

We also anticipate we will have sufficient cash on hand, as well as available liquidity under the Facility, to pay outstanding principal balances of our existing notes by the respective maturity dates. Another potential source of liquidity is access to public capital markets, subject to market conditions. We ~~intend to obtain additional liquidity by accessing~~may access the capital markets to repay the outstanding balance, if ~~these~~our sources of liquidity have been used for other strategic purposes by the time of maturity. Refer to Debt Instruments below.

Sources and Uses of Cash and Cash Equivalents


		Six Months Ended June 30,							Six Months Ended June 30,
(in millions)	(in millions)	2019		2018		(in millions)	2020		2019
Net cash provided by (used in) operating activities		$	197.1	$	(2.8)
Net cash (used in) provided by investing activities		(311.9)		674.1
Net cash used in financing activities		(267.2)		(285.9)
Net cash provided by operating activities						Net cash provided by operating activities	$	226.3	$	197.1
Net cash used in investing activities						Net cash used in investing activities	(50.0)		(311.9)
Net cash provided by (used in) financing activities						Net cash provided by (used in) financing activities	214.7		(267.2)
Effect of foreign currency exchange rate changes on cash	Effect of foreign currency exchange rate changes on cash	0.4		—		Effect of foreign currency exchange rate changes on cash	(4.5)		0.4
Change in cash and cash equivalents	Change in cash and cash equivalents	$	(381.6)	$	385.4	Change in cash and cash equivalents	$	386.5	$	(381.6)

Operating Activities

We generated operating cash flows of $226.3 million for the first six months of 2020 (including working capital uses of $69.0 million), compared with $197.1 million for the first six months of 2019 (including working capital uses of $153.8 million)~~, compared with $(2.8) million for the first six months of 2018 (including working capital uses of $276.7 million)~~. Higher operating cash flows in the first six months of ~~2019~~2020 primarily reflect ~~higher cash earnings, more efficient investment~~declines in net working capital ~~and non-recurrence~~as a result of ~~cash tax payments for the sale of Carlisle FoodService Products.~~

decline in sales volumes as well as lower raw material costs at CCM.

Investing Activities

Cash used in investing activities of $50.0 million for the first six months of 2020 primarily reflected capital expenditures of $48.5 million. Cash used in investing activities of $311.9 million for the first six months of 2019 primarily reflected the acquisitions of Petersen, net of cash acquired, for $202.0 million and MicroConnex, net of cash acquired, for $46.0 million, and capital expenditures of $41.0 million.

Financing Activities

Cash provided by ~~investing~~financing activities of ~~$674.1~~$214.7 million ~~for~~in the first six months of ~~2018~~2020 primarily ~~reflects the sale of CFS for gross~~reflected net proceeds ~~of $754.6 million,~~from our bond offering, partially offset by ~~capital expenditures~~the early redemption of ~~$66.9 million.~~

~~Financing Activities~~

our senior notes due December 15, 2020, and financing costs associated with our bond offering. Additionally, we used cash of $191.8 million for share repurchases and $56.0 million for dividend payments, reflecting the increased dividend of $1.00 per share. Cash used in financing activities of $267.2 million induring the first six months of 2019 primarily reflected $232.1 million of share repurchases and $46.2 million of dividend payments, reflecting the increased dividend of $0.80 per share. Cash used in financing activities of $285.9 million during the first six months of 2018 primarily reflected $235.7 million of share repurchases and $45.6 million of dividend payments.

~~Outlook~~

Our priorities for the use of cash are to invest in growth and performance improvement opportunities for our existing businesses through capital expenditures, pursue strategic acquisitions that meet shareholder return criteria, pay dividends to shareholders and return value to shareholders through share repurchases.

Debt Instruments

Senior Notes

On February 28, 2020, we issued a notice for the redemption in full of our $250.0 million aggregate principal amount of its outstanding 5.125% notes due December 15, 2020 (the “2020 Notes”). The 2020 Notes were redeemed on March 29, 2020 at the redemption price of $262.1 million. We recognized a loss on extinguishment of debt totaling $8.8 million in the first quarter of 2020.

We also have senior unsecured notes outstanding of ~~$250.0 million due December 15, 2020 (at a stated interest rate of 5.125%),~~ $350.0 million due November 15, 2022 (at a stated interest rate of 3.75%), $400.0 million due December 1, 2024 (at a stated interest rate of 3.5%) and $600.0 million due December 1, 2027 (at a stated interest rate of 3.75%) that are rated BBB by Standard & Poor’s and Baa2 by Moody’s.

Revolving Credit Facility (the "Facility")

During the ~~first~~ six months ~~of 2019, we had no~~ended June 30, 2020, borrowings ~~or repayments~~ under the ~~Facility.~~Facility totaled $500.0 million with a weighted average interest rate of 1.9%, and repayments totaled $500.0 million. As of June 30, ~~2019,~~2020, there were no borrowings under the Facility ~~had no outstanding balance~~ and $1.0 billion ~~available for use.~~of availability. During the year ended and as of December 31, 2019 there were no borrowings under the Facility.

Debt Covenants

We are required to meet various restrictive covenants and limitations under our senior notes and revolving credit facility including certain leverage ratios, interest coverage ratios and limits on outstanding debt balances held by certain subsidiaries. We were in compliance with all covenants and limitations as of June 30, ~~2019~~2020 and December 31, ~~2018.~~2019.

Refer to Note 1412 for further information on our debt instruments.

New Accounting Pronouncements

Refer to Note 2 for more information regarding new accounting pronouncements.

Critical Accounting Estimates

Our significant accounting policies are more fully described in Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2019. In preparing the Consolidated Financial Statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”), the Company’s management must make informed decisions which impact the reported amounts and related disclosures. Such decisions include the selection of the appropriate accounting principles to be applied and assumptions on which to base estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates, including those related to revenue recognition, extended product warranties, goodwill and indefinite-lived intangible assets, valuation of long-lived assets, and income taxes on an ongoing basis. The Company bases its estimates on historical experience, terms of existing contracts, our observation of trends in the industry, information provided by our customers and information available from other outside sources, that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amount of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.

Subsequent Measurement of Goodwill

Goodwill is not amortized but is tested annually, or more often if impairment indicators are present, for impairment at a reporting unit level, based on a comparison of the fair value of the reporting unit with its carrying amount. Goodwill is tested for impairment via a one-step process by comparing the fair value of goodwill with its carrying amount. We recognize an impairment for the amount by which the carrying amount exceeds the fair value. We generally use both an income approach utilizing the discounted cash flow method ("DCF") and a market approach utilizing the

3233

public company market multiple method, when testing for impairment. The key techniques and assumptions used include:


Valuation Technique						Key Assumptions
Discounted future cash flows						•Estimated future revenues •Earnings before interest, taxes, depreciation and amortization ("EBITDA") margins •Discount rates
Market multiple method						•Peer public company group •Financial performance of reporting units relative to peer public company group

In the second quarter of 2020, changes in facts and circumstances and general market declines from COVID-19 resulted in reduced operating results. We considered these circumstances and the potential long-term impact on cash flows associated with our reporting units and determined that an indicator of possible impairment existed within our CFT and CBF reporting units. Accordingly, we tested our goodwill for impairment as of June 30, 2020. Those reporting units were tested for impairment using the quantitative approach described above, resulting in a fair value for the CFT reporting unit that exceeded the carrying amount by approximately 10 percent, and a fair value for the CBF reporting unit that substantially exceeded the carrying amount. The carrying amount of goodwill for the CFT and CBF reporting units was $186.2 million and $96.4 million, respectively.

We will continue to closely monitor actual results versus expectations as well as whether and to what extent any significant changes in current events or conditions, including changes to the impacts of COVID-19 on our business, result in corresponding changes to our expectations about future estimated cash flows, the weighted average cost of capital ("WACC") and market multiples. If our adjusted expectations of the operating results, both in size and timing, of CFT and CBF do not materialize, if the WACC increases (based on increases in interest rates, market rates of return or market volatility) or if market multiples decline, we may be required to record goodwill impairment charges, which may be material.

While we believe our conclusions regarding the estimates of fair value of our reporting units are appropriate, these estimates are subject to uncertainty and by nature include judgments and estimates regarding various factors. These factors include the rate and extent of growth in the markets that our reporting units serve, the realization of future sales price and volume increases, fluctuations in exchange rates, fluctuations in price and availability of key raw materials, future operating efficiencies and, as it pertains to discount rates, the volatility in interest rates and costs of equity.

Refer to Note 11 for more information regarding goodwill.

Subsequent Measurement of Indefinite-Lived Intangible Assets

As discussed above, indefinite-lived intangible assets are recognized and recorded at their acquisition-date fair value. Intangible assets with indefinite useful lives are not amortized but are tested annually at the appropriate unit of account, which generally equals the individual asset, or more often if impairment indicators are present. Indefinite-lived intangible assets are tested for impairment via a one-step process by comparing the fair value of the intangible asset with its carrying amount. We recognize an impairment charge for the amount by which the carrying amount exceeds the intangible asset's fair value. We generally estimate the fair value of our indefinite-lived intangible assets consistent with the techniques noted above using our expectations about future cash flows, discount rates and royalty rates for purposes of the annual test. We monitor for significant changes in those assumptions during interim reporting periods. We also periodically re-assess indefinite-lived intangible assets as to whether its useful lives can be determined, and if so, we would begin amortizing any applicable intangible asset.

In the second quarter of 2020, changes in facts and circumstances and general market declines from COVID-19 resulted in reduced revenues. We considered these circumstances and the potential long-term impact on revenues associated with its indefinite-lived trade names and determined that an indicator of possible impairment existed. Accordingly, we performed a quantitative impairment analysis to determine the fair values of our CFT and CBF indefinite-lived trade names using the method described above.

Based on the output of the analysis, we determined that the fair value of one CFT trade name with a carrying value of $39.0 million exceeded the carrying amount by less than 10 percent. The remaining CFT and CBF indefinite-lived trade names substantially exceeded their carrying amounts. Accordingly, no impairment charges were required as of June 30, 2020. The carrying amount of indefinite-lived trade names for CFT and CBF were $129.1 million and $42.0 million, respectively.

We will continue to closely monitor actual results versus expectations as well as whether and to what extent any significant changes in current events or conditions, including changes to the impacts of COVID-19 on our business, result in corresponding changes to our expectations about future estimated revenues and the weighted average cost of capital. If our adjusted expectations of the revenues, both in size and timing, of CFT and CBF trade names do not materialize or if the WACC increases (based on increases in interest rates, market rates of return or market volatility), we may be required to record trade name impairment charges, which may be material.

Refer to Note 11 for more information regarding intangible assets.

Items Affecting Comparability

Items affecting comparability include costs, and losses or gains related to, among other things, growth and profitability improvement initiatives and other events outside of core business operations (such as asset impairments, exit and disposal and facility rationalization charges, costs of and related to acquisitions, litigation settlement costs, gains and losses from and costs related to divestitures, idle capacity and labor costs, net of subsidies, losses on debt extinguishment and discrete tax items). Because these items affect our, or any particular operating segment's, financial condition or results in a specific period in which they are recognized, we believe it is appropriate to present the total of these items to provide information regarding the comparability of results of operations period to period. The components of items affecting comparability follows:

Three Months Ended June 30, 2019 Three Months Ended June 30, 2018
(in millions, except per share amounts) Impact to Operating Income Impact to Income from Continuing Operations Impact to Diluted EPS from Continuing Operations Impact to Operating Income Impact to Income from Continuing Operations Impact to Diluted EPS from Continuing Operations
Exit and disposal costs $ 1.5 $ 1.2 $ 0.02 $ 4.6 $ 3.4 $ 0.05
Other facility rationalization costs 0.9 0.7 0.01 2.7 2.0 0.04
Acquisition related costs:
Inventory step-up amortization 0.7 0.5 0.01 0.4 0.3 0.01
Other acquisition costs 1.4 1.1 0.02 0.5 0.5 0.01
Litigation costs — — — 1.4 1.1 0.02
Gain and costs from step acquisition — (0.3) — — — —
Gains from divestitures — — — (1.9) (1.6) (0.03)
Discrete tax items¹
— (5.1) (0.09) — (4.6) (0.07)
Total items affecting comparability $ 4.5 $ (1.9) $ (0.03) $ 7.7 $ 1.1 $ 0.03


		Six Months Ended June 30, 2019										Six Months Ended June 30, 2018											Three Months Ended June 30, 2020				Three Months Ended June 30, 2019
(in millions, except per share amounts)	(in millions, except per share amounts)	Impact to Operating Income		Impact to Income from Continuing Operations		Impact to Diluted EPS from Continuing Operations		Impact to Operating Income		Impact to Income from Continuing Operations		Impact to Diluted EPS from Continuing Operations		(in millions, except per share amounts)	Impact to Operating Income		Impact to Income from Continuing Operations		Impact to Diluted EPS from Continuing Operations		Impact to Operating Income		Impact to Income from Continuing Operations		Impact to Diluted EPS from Continuing Operations
Exit and disposal costs	Exit and disposal costs	$	8.3	$	6.3	$	0.11	$	7.7	$	5.8	$	0.09	Exit and disposal costs	$	8.3	$	6.3	$	0.11	$	1.5	$	1.2	$	0.02
Other facility rationalization costs	Other facility rationalization costs	2.3		1.8		0.03		4.9		3.7		0.06		Other facility rationalization costs	0.4		0.3		0.01		0.9		0.7		0.01
Acquisition related costs:	Acquisition related costs:													Acquisition related costs:
Inventory step-up amortization	Inventory step-up amortization	1.2		0.9		0.01		0.4		0.3		0.01		Inventory step-up amortization	—		—		—		0.7		0.5		0.01
Other acquisition costs	Other acquisition costs	2.9		2.2		0.04		1.6		1.3		0.02		Other acquisition costs	4.9		3.7		0.07		1.4		1.1		0.02
Idle capacity and labor costs, net of subsidies														Idle capacity and labor costs, net of subsidies	3.8		2.8		0.05		—		—		—

Litigation costs		—		—		—		1.4		1.1		0.02
Gain from contingent consideration		(3.0)		(3.0)		(0.05)		—		—		—
Gain and costs from step acquisition	Gain and costs from step acquisition	—		(0.3)		—		—		—		—		Gain and costs from step acquisition	—		—		—		—		(0.3)		—
Gains from divestitures		—		—		—		(3.9)		(3.1)		(0.05)
Discrete tax items¹		—		(5.0)		(0.09)		—		(3.5)		(0.06)

Indemnification losses														Indemnification losses	—		2.0		0.04		—		—		—
Discrete tax items⁽¹⁾														Discrete tax items⁽¹⁾	—		(1.4)		(0.03)		—		(5.1)		(0.09)
Total items affecting comparability	Total items affecting comparability	$	11.7	$	2.9	$	0.05	$	12.1	$	5.6	$	0.09	Total items affecting comparability	$	17.4	$	13.7	$	0.25	$	4.5	$	(1.9)	$	(0.03)

^1.(1)In order to provide better information to the user, items affecting comparability include all discrete tax items in this period and all comparative periods.


	Six Months Ended June 30, 2020											Six Months Ended June 30, 2019
(in millions, except per share amounts)	Impact to Operating Income		Impact to Income from Continuing Operations			Impact to Diluted EPS from Continuing Operations		Impact to Operating Income		Impact to Income from Continuing Operations		Impact to Diluted EPS from Continuing Operations
Exit and disposal costs	$	13.1	$	9.9		$	0.18	$	8.3	$	6.3	$	0.11
Other facility rationalization costs	1.9		1.4			0.03		2.3		1.8		0.03
Acquisition related costs:
Inventory step-up amortization	0.2		0.2			—		1.2		0.9		0.01
Other acquisition costs	5.4		4.1			0.07		2.9		2.2		0.04
Idle capacity and labor costs, net of subsidies	7.8		5.8			0.10		—		—		—

Gain from contingent consideration	—		—			—		(3.0)		(3.0)		(0.05)
Gain from step acquisition, net	—		—			—		—		(0.3)		—
Gains from divestitures	(0.8)		(0.6)			(0.01)		—		—		—
Loss on debt extinguishment	—		6.6			0.12		—		—		—
Indemnification losses	—		3.1			0.06		—		—		—
Discrete tax items⁽¹⁾	—		(5.4)		⁽²⁾	(0.10)		—		(5.0)		(0.09)
Total items affecting comparability	$	27.6	$	25.1		$	0.45	$	11.7	$	2.9	$	0.05

⁽¹⁾In order to provide better information to the user, items affecting comparability include all discrete tax items in this period and all comparative periods.

⁽²⁾Excludes $0.1 million of discrete tax items related to indemnification asset write-offs which had zero impact to income from continuing operations and EPS from continuing operations.

The impact to income from continuing operations reflects the tax effect of items affecting comparability based on the statutory rate in the jurisdiction in which the expense or income is deductible or taxable. The per share impact of items affecting comparability to each period is based on diluted shares outstanding using the two-class method (refer to Note 6)5).

Outlook

Revenues

In light of current economic uncertainty caused by COVID-19, full-year 2020 revenue guidance has been withdrawn until a clearer picture emerges for our businesses.

Cash Flows

Despite the continued uncertainty in global markets resulting from COVID-19, we believe we have sufficient cash on hand, availability under the Facility and operating cash flows to meet our business requirements for at least the next 12 months. At the discretion of management, the Company may use available cash on non-operating purchases including capital expenditures for worldwide manufacturing, dividends, common stock repurchases, acquisitions and strategic investments.

Capital expenditures in 2020 are expected to be between $100 million and $110 million, which primarily includes continued investments in CCM facilities. Planned capital expenditures for 2020 include business sustaining projects, cost reduction efforts and new product expansion. In response to declining demand attributable to COVID-19, we may make selected adjustments to our expected capital expenditures in line with our capital deployment strategy.

Forward-Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of ~~1995.~~1995, including statements regarding the potential or expected impacts of the global COVID-19 pandemic. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," ~~"forecast"~~"forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties. It is possible that our future performance may differ materially from current expectations expressed in these forward-looking statements, due to

a variety of factors such as: risks from the global COVID-19 pandemic, including, for example, expectations regarding the impact of COVID-19 on our businesses, including on customer demand, supply chains and distribution systems, production,

our ability to maintain appropriate labor levels, our ability to ship products to our customers, our ability to obtain financial and tax benefits from the recently-passed CARES Act, our future results, or our full-year financial outlook; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost-effective basis; our mix of products/services; increases in raw material costs which cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental and industry regulations; threats associated with and efforts to combat terrorism; protection and validity of patent and other intellectual property rights; the successful integration and identification of our strategic acquisitions; the cyclical nature of our businesses; and the outcome of pending and future litigation and governmental proceedings. In addition, such statements could be affected by general industry and market conditions and growth rates, the condition of the financial and credit markets and general domestic and international economic conditions including interest rate and currency exchange rate fluctuations. Further, any conflict in the international arena may adversely affect general market conditions and our future performance. We undertake no duty to update forward-looking statements.

Item 3. Quantitative and Qualitative Disclosure about Market Risk

There have been no material changes in the Company’s market risk for the six months ended June 30, ~~2019.~~2020. For additional information, refer to "PART II—Item 7A. Quantitative and Qualitative Disclosures About Market Risk" of the Company’s ~~2018~~2019 Annual Report on Form 10-K.

Item 4. Controls and Procedures

a.Evaluation of disclosure controls and procedures. Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon that evaluation and as of June 30, ~~2019,~~2020, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.

b.Changes in internal controls. During the first six months of ~~2019,~~2020, there were no changes in the Company's internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II

Item 1. Legal Proceedings

~~Litigation~~

Over the years, we have been named as a defendant, along with numerous other defendants, in lawsuits in various state courts in which plaintiffs have alleged injury due to exposure to asbestos-containing brakes, which Carlisle manufactured in limited amounts between the late-1940’s and the mid-1980’s. In addition to compensatory awards, these lawsuits may also seek punitive damages. We typically obtain dismissals or settlements of our asbestos-related lawsuits with no material effect on our financial condition, results of operations, or cash flows. We maintain insurance coverage that applies to our defense costs and payments of settlements or judgments in connection with asbestos-related lawsuits. At this time, we believe that the resolution of our pending asbestos claims will not have a material impact on our financial condition, results of operations, or cash flows, although these matters could result in the Company being subject to monetary damages, costs or expenses, and charges against earnings in particular periods.

In addition, we may occasionally be involved in various other legal actions arising in the normal course of business. In the opinion of management, the ultimate outcome of such actions, either individually or in the aggregate, are not expected to have a material adverse effect on the consolidated financial position or annual operating cash flows of the Company.

~~Environmental Matters~~

We are subject to increasingly stringent environmental laws and regulations, including those relating to air emissions, wastewater discharges, chemical and hazardous waste management and disposal. Some of these environmental laws hold owners or operators of land or businesses liable for their own and for previous owners’ or operators’ releases of hazardous or toxic substances or wastes. Other environmental laws and regulations require the obtainment, and compliance with, environmental permits. To date, costs of complying with environmental, health

and safety requirements have not been material, and we do not have any significant accruals related to potential future costs of environmental remediation as of June 30, 2019, nor are any asset retirement obligations recorded as of that date. The nature of our operations and our long history of industrial activities at certain of our current or former facilities, as well as those acquired could potentially result in material environmental liabilities.

While we must comply with existing and pending climate change legislation, regulation, international treaties or accords, current laws and regulations do not have a material impact on our business, capital expenditures or financial position. Future events, including those relating to climate change or greenhouse gas regulation could require the Company to incur expenses related to the modification or curtailment of operations, installation of pollution control equipment, or investigation and cleanup of contaminated sites.None.

Item 1A. Risk Factors

~~During the six months ended June 30, 2019,~~Except as noted below, there ~~were~~have been no material changes toin the Company's risk factors disclosed in "PART I—Item 1A. Risk Factors" ~~of the Company’s 2018~~in our 2019 Annual Report on Form 10-K.

The Company is subject to risks arising from global pandemics including the coronavirus ("COVID-19") pandemic.

The Company’s businesses operate in market segments currently being impacted by the COVID-19 pandemic. Operating during a global pandemic exposes the Company to a number of risks, including diminished demand for our products and our customers’ products, suspensions in the operations of our manufacturing facilities, maintenance of appropriate labor levels and our ability to ship products to our customers, interruptions in our supply chains and distribution systems, increases in operating costs related to pay and benefits for our employees, collection of trade receivables in accordance with their terms, potential impairment of goodwill and long-lived assets; all of which, in the aggregate, could have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows.

We have experienced, and expect to continue to experience, diminished demand for our products as a result of COVID-19. The decline in domestic and international passenger airline travel caused by COVID-19 is negatively impacting demand for our products sold to customers operating in the commercial aerospace industry. COVID-19 related delays in nonresidential replacement starts in certain regions are negatively impacting demand for our

products sold to customers operating in the nonresidential construction materials industry. While these COVID-19 related impacts have not to date, in the aggregate, had a material adverse impact on the Company, we are unable to predict the extent or duration of these impacts as they will depend on future developments, which are highly uncertain and cannot be predicted at this time, such as the duration of the coronavirus outbreak, the timing and extent of increased passenger airline travel and nonresidential construction and construction repair and replacement activity, and the continued ability of our businesses to continue to operate within all applicable COVID-19 related government rules and regulations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table summarizes the repurchase of common stock during the three months ended June 30, ~~2019:~~2020:

(shares in thousands) Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs¹
April 2019 47 $ 125.28 — 6,394
May 2019 289 135.91 288 6,106
June 2019 262 136.82 262 5,844
Total 598 550


(in millions except per share)	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs⁽¹⁾
April	0.2	$	121.38	0.2	3.8
May	0.2	114.93		0.2	3.6
June	0.1	128.27		0.1	3.5
Total	0.5			0.5

^1.(1)Represents the remaining total number of shares that can be repurchased under the Company’s stock repurchase program. ~~On February 5, 2019, the Board approved a 5 million share increase in the Company's stock repurchase programs.~~

The Company may also reacquire shares outside of the repurchase program from time to time in connection with the forfeiture of shares in satisfaction of tax withholding obligations from the vesting of share-based compensation. There were ~~approximately 48 thousand~~a negligible number of shares reacquired in transactions outside of the share repurchase program during the ~~six~~three months ended June 30, ~~2019.~~2020.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit

Number

Filed with this Form 10-Q

Incorporated by Reference

Exhibit Title

Form

File No.

Date Filed

3.1

Restated Certificate of Incorporation of the Company.

10-Q

001-9278

10/21/2015

3.2

Amended and Restated Bylaws of the Company.

8-K

001-9278

12/14/2015

4.1^P

Form of Trust Indenture between the Company and Fleet National Bank.

S-3

333-16785

11/26/1996

4.2

First Supplemental Indenture, dated as of August 18, 2006, among the Company, U.S. Bank National Association (as successor to State Street Bank and Trust Company, as successor to Fleet National Bank) and The Bank of New York Mellon Trust Company, N.A.

8-K

001-9278

8/18/2006

4.3

Second Supplemental Indenture, dated as of December 9, 2010, among the Company, U.S. Bank National Association (as successor to State Street Bank and Trust Company, as successor to Fleet National Bank) and The Bank of New York Mellon Trust Company, N.A.

8-K

001-9278

12/10/2010

4.4

Third Supplemental Indenture, dated as of November 20, 2012, among the Company, U.S. Bank National Association (as successor to State Street Bank and Trust Company, as successor to Fleet National Bank) and The Bank of New York Mellon Trust Company, N.A.

8-K

001-9278

11/20/2012

4.5

Form of 3.500% Notes due 2024.

8-K

001-9278

11/16/2017

4.6

Form of 3.750% Notes due 2027.

8-K

001-9278

11/16/2017

4.7

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.

10-K

001-9278

2/10/2020

4.8

Fourth Supplemental Indenture, dated as of February 20, 2020, among the Company, U.S. Bank National Association (as successor to State Street Bank and Trust Company, as successor to Fleet National Bank) and The Bank of New York Mellon Trust Company, N.A.

8-K

001-9278

2/28/2020

4.9

Form of 2.750% Notes due 2030.

8-K

001-9278

2/28/2020

10.1

Amended and Restated Director Deferred Compensation Plan.

31.1

Certification of Principal Executive Officer pursuant to Rule 13a-14(a)/15d-14(a).

31.2

Certification of Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).

32.1

Section 1350 Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

~~The instance document does not appear in the interactive data file because its~~Inline XBRL ~~tags are embedded within the inline XBRL document.~~Instance

101.SCH

Inline XBRL Taxonomy Extension Schema ~~Document~~

101.CAL

Inline XBRL Taxonomy Extension Calculation ~~Linkbase Document~~

~~101.DEF~~

~~XBRL Taxonomy Extension Definition Linkbase Document~~

101.LAB

Inline XBRL Taxonomy Extension ~~Label Linkbase Document~~Labels

101.PRE

Inline XBRL Taxonomy Extension Presentation ~~Linkbase Document~~

101.DEF

Inline XBRL Taxonomy Extension Definition

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

^P Indicates paper filing.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CARLISLE COMPANIES INCORPORATED

Date:

July ~~25, 2019~~23, 2020

By:

/s/ Robert M. Roche

Robert M. Roche

Vice President and Chief Financial Officer

3740


	June 30, 2019
(in millions)	As Reported		Balances Without Adoption of ASC 842		Effect of Change Higher/(Lower)
Other current assets	$	60.0	$	60.5	$	(0.5)
Other long-term assets	106.4		36.8		69.6
Accrued liabilities and other	248.8		227.4		21.4
Other long-term liabilities	365.3		317.6		47.7


(in millions)	Three Months Ended June 30, 2018		Six Months Ended June 30, 2018
Revenues	$	—	$	69.5

Cost of goods sold	—		49.5
Other operating expenses, net	1.0		15.8
Operating (loss) income	(1.0)		4.2
Other non-operating (income) expense, net	—		—
(Loss) income from discontinued operations before income taxes	(1.0)		4.2
(Loss) gain on sale of discontinued operations	(0.3)		293.5
(Benefit) provision for income taxes	(0.3)		47.0
(Loss) income from discontinued operations	$	(1.0)	$	250.7


	Three Months Ended June 30,						Six Months Ended June 30,
(in millions, except share amounts presented in thousands)	2019		2018		2019		2018
(Loss) income from discontinued operations attributable to common shareholders for basic and diluted earnings per share	$	(0.1)	$	(0.9)	$	1.9	$	249.1
Net income attributable to common shareholders for basic and diluted earnings per share	152.5		113.0		231.6		420.4
Anti-dilutive stock options excluded from EPS calculation¹	2		711		358		644


(in millions)	Remainder of 2019		2020		2021		2022		2023		2024		Thereafter
Extended service warranties	$	10.7	$	20.6	$	19.6	$	18.4	$	17.2	$	16.1	$	126.7


(in millions)	Three Months Ended June 30, 2019		Six Months Ended June 30, 2019
Operating lease cost	$	6.8	$	13.2
Variable lease cost	1.8		3.3
Short-term lease cost	0.8		1.5
Total lease cost	$	9.4	$	18.0


	Three Months Ended June 30, 2019										Three Months Ended June 30, 2018
(in millions, except per share amounts)	Impact to Operating Income		Impact to Income from Continuing Operations		Impact to Diluted EPS from Continuing Operations		Impact to Operating Income		Impact to Income from Continuing Operations		Impact to Diluted EPS from Continuing Operations
Exit and disposal costs	$	1.5	$	1.2	$	0.02	$	4.6	$	3.4	$	0.05
Other facility rationalization costs	0.9		0.7		0.01		2.7		2.0		0.04
Acquisition related costs:
Inventory step-up amortization	0.7		0.5		0.01		0.4		0.3		0.01
Other acquisition costs	1.4		1.1		0.02		0.5		0.5		0.01

Litigation costs	—		—		—		1.4		1.1		0.02
Gain and costs from step acquisition	—		(0.3)		—		—		—		—

Gains from divestitures	—		—		—		(1.9)		(1.6)		(0.03)
Discrete tax items¹	—		(5.1)		(0.09)		—		(4.6)		(0.07)
Total items affecting comparability	$	4.5	$	(1.9)	$	(0.03)	$	7.7	$	1.1	$	0.03


(shares in thousands)	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs¹
April 2019	47	$	125.28	—	6,394
May 2019	289	135.91		288	6,106
June 2019	262	136.82		262	5,844
Total	598			550